columbia university college of physicians and …

1

COLUMBIA UNIVERSITY

COLLEGE OF PHYSICIANS AND SURGEONS

Curriculum Vitae

June 15, 2018

Personal Data:

Selim M. Arcasoy, MD, MPH, FCCP, FACP, FAST

Birthdate: May 4, 1966

Birthplace: Seattle, WA

Citizenship: U.S.

Undergraduate Training:

1977-84 Tarsus American College, Tarsus, Turkey

1984-90 Degree: M.D.

Ege University School of Medicine, Izmir, Turkey

Postgraduate Training and Fellowship Appointments:

1990-91 Internship, State University of New York Health Science Center at Brooklyn, New York

1991-93 Residency, State University of New York

Health Science Center at Brooklyn, New York

1993-94 Chief Residency, State University of New York

Health Science Center at Brooklyn, New York

1994-97 Fellowship, Pulmonary and Critical Care Medicine

University of Pittsburgh, Pennsylvania

1997-98 Research Fellowship, Pulmonary and Critical Care Medicine

University of Pittsburgh, Pennsylvania

2011-13 Executive Master of Public Health in Healthcare Policy Management

Columbia University Mailman School of Public Health, New York

Degree: M.P.H.

Board Qualifications:

1993 American Board of Internal Medicine

Certification in Internal Medicine


Certification in Pulmonary Medicine


Certification in Critical Care Medicine

Selim M. Arcasoy, M.D., M.P.H. June 15, 2018

2


Re-certification in Internal Medicine, Pulmonary and Critical Care Medicine


Re-certification in Internal Medicine


Re-certification in Pulmonary Medicine


Re-certification in Critical Care Medicine

Licensures:

1993 New York State Medical License- 1943571

1994 Pennsylvania State Medical License-MD 052356 L

2004 New Jersey State Medical License- 25MA07753500

Military Service:

None

Professional Organizations and Scientific Societies:

American College of Physicians

American Thoracic Society

American College of Chest Physicians

International Society for Heart and Lung Transplantation

American Society of Transplantation

United Network for Organ Sharing

Pulmonary Alveolar Proteinosis Foundation- Clinical Advisory Board

New York State Thoracic Society, Medical Section of the American Lung Association of New York, Inc.,

Chapter of the American Thoracic Society

New York Cardiothoracic Transplant Consortium, Inc., Member, Board of Directors

NewYork-Presbyterian James Lenox Society

The DeLamar Society, Columbia University Mailman School of Public Health

Organizing and Leadership Roles in Scientific Societies and Meetings

American Society of Transplantation Thoracic Organ Committee 2002-2006

American Society of Transplantation Training & Workforce Committee 2002-2004

American College of Chest Physicians

Transplant Immunology Network/Steering Committee 2002-2006


3

International Society for Heart and Lung Transplantation Scientific Program Committee Member for 2003

Meeting, Vienna, Austria

American Thoracic Society 2003 Meeting, Seattle, WA, Organizer and Chair of Symposium entitled “Advanced

Lung Disease 2003. Lung Transplantation and More”

American Society of Transplantation Thoracic Organ Committee, Co-chair 2003-2004

American College of Chest Physicians, CHEST 2003 Meeting, Abstract Review Committee

American College of Chest Physicians, CHEST 2003 Meeting, Organizer and Moderator of Panel Discussion on

“Advanced Lung Disease and Timing of Lung Transplantation 2003”

American Transplant Congress 2004, Boston, MA, Co-chair of Lung Program Committee and Abstract Review

Committee

International Society for Heart and Lung Transplantation, Scientific Council on Pulmonary Transplantation;

Working Group on Primary Graft Failure; Chair, Subgroup 3: Outcomes and Predictors of Primary Graft Failure,

2004


Committee on the Revision of International Guidelines for the Selection of Lung Transplant Candidates, 2004

American Society of Transplantation Thoracic Organs Committee, Chair 2004-2005

American Society of Transplantation Representative (AST at Large Member) to the United Network for Organ

Sharing/Organ Procurement and Transplantation Network Thoracic Organ Transplant Committee 2004-2005

American Society of Transplantation/The Thoracic Surgery Foundation for Research and Education Joint

Fellowship Grant Ad Hoc Committee 2004-2005

American Thoracic Society 100th International Meeting, Facilitator of Poster Session on Lung Transplantation;

Clinical Issues II, Orlando, FL, 2004

International Society for Heart and Lung Transplantation, Abstract Review Committee, and Concurrent Session

Moderator, Twenty-fifth Anniversary Meeting, Philadelphia, PA 2005

American Society of Transplantation Nominating Committee, Member 2004-2005

American College of Chest Physicians, CHEST 2005, Montreal, Canada

Organizer and Chair, Panel Discussion, ABCDs of Lung Transplantation for the Community Pulmonologist

American Society of Transplantation Patient Education Web Site Committee 2005

American Society of Transplant Surgeons and American Society of Transplantation, National Institute of Allergy

and Infectious Diseases, Retransplantation Conference, Lung Workgroup, March 2006

American College of Chest Physicians, CHEST 2006 Meeting, Abstract Review Committee

American College of Chest Physicians, Organizer and Chair, Panel Discussion on Racial and Ethnic Disparities in

the Prognosis and Management of Pulmonary Diseases, CHEST 2006, Salt Lake City, Utah


4

American College of Chest Physicians, Moderator, Slide Presentations of Original Investigation. Interstitial Lung

Disease II, CHEST 2006, Salt Lake City, Utah

The 2006 American Society of Transplantation/The CHEST Foundation Clinical Research Award in Lung

Transplantation, Grant Reviewer

American College of Chest Physicians Transplant Immunology Network Steering Committee, Vice Chair

2006-2008

American College of Chest Physicians, Abstract Review Committee, CHEST 2007, Chicago, IL

International Society of Heart and Lung Transplantation, Abstract Review Committee and Symposium

Chair, ISHLT Meeting 2008, Boston, MA

Member and Co-chair of Bronchiolitis Obliterans Section, Lung Transplantation: A Comprehensive,

Evidence-Based Guideline Committee, American Thoracic Society Meeting 2008, Toronto, Canada

Member, Editorial Board of Turkish Journal of Thorax 2008-

American College of Chest Physicians Transplant Immunology Network Steering Committee, Chair

2008-2010

Member, Council of Networks, American College of Chest Physicians 2008-2010

International Society of Heart and Lung Transplantation, 29th Annual Meeting 2009, Paris, France,

Abstract Review Committee and Symposium Co-Chair, Concurrent session 45: Primary Graft

Dysfunction: Evaluating Mechanisms in the Lung

American College of Chest Physicians, Program Committee member for CHEST 2009 Meeting, San

Diego, CA

American Society of Transplantation, Abstract Review Committee, American Transplant Congress 2009,

Boston, MA

Member, Alpha-1 Foundation, Medical and Scientific Advisory Committee, 2009-10

Vice-Chair, Alpha-1 Foundation Transplant Issues Working Group, 2009-10

American College of Chest Physicians, Program Committee member for CHEST 2010 Meeting,

Vancouver, Canada

American Society of Transplantation, Abstract Review Committee, American Transplant Congress 2010

International Society of Heart and Lung Transplantation, 30th Annual Meeting 2010, Chicago, USA,

Abstract Review Committee and Sunrise Symposium Co-Chair: Linking outcomes and quality of life

after lung transplant.

International Society for Heart and Lung Transplantation, Scientific Program Committee Member for 31st Annual

Meeting, 2011, San Diego, CA


5

Organizer and Chair, Clinical Controversy: Lung Allocation System in the United States: Implications for

the Patient with Advanced Lung Disease, American College of Chest Physicians, CHEST 2010 Meeting,

Vancouver, Canada

Organizer and Chair, Panel Discussion: State-of-the-Art Management of End Stage Lung Disease,

American College of Chest Physicians, CHEST 2010 Meeting, Vancouver, Canada

New York Cardiothoracic Transplant Consortium, Member of the Board of Directors and Vice-President

2011-2013

Designated mentor, Junior Faculty Mentor Lunch, International Society for Heart and Lung Transplantation 31st

Annual Meeting, 2011, San Diego, CA

Chair, Quandary at the Lung Transplant Board Meeting, International Society for Heart and Lung Transplantation

31st Annual Meeting, 2011, San Diego, CA

Co-chair, Scientific Symposium: “Stem Cells and Regenerative Medicine in Lung Disease and

Transplantation”, American Thoracic Society International Meeting, 2011, Denver, CO

Moderator and Speaker, Symposium on Lung transplantation, Overview and Case Presentations, Turkish

Thoracic Society and Turkish Society of Chest Surgery, Istanbul, Turkey, 2014

American Society of Transplantation, Abstract Review Committee, American Transplant Congress 2013-

2017

New York Cardiothoracic Transplant Consortium, Member of the Board of Directors and Treasurer 2015-

The Lung Review Board, Member, United Network for Organ Sharing, 2015-2017


Working Group on Primary Graft Failure Guidelines: Risk factors and outcomes of Primary Graft Failure, 2015-

17

Academic Appointments:

2013- Dickinson W. Richards, Jr. Professor of Medicine (in Pediatrics), Department of Medicine,

Pulmonary, Allergy and Critical Care Division, Columbia University College of Physicians

and Surgeons, New York, NY

2008-2013 Professor of Clinical Medicine (in Pediatrics), Department of Medicine, Pulmonary, Allergy

and Critical Care Division, Columbia University College of Physicians and Surgeons, New

York, NY

2003-2008 Associate Professor of Clinical Medicine, Department of Medicine, Pulmonary, Allergy and

Critical Care Division, Columbia University College of Physicians and Surgeons, New York,

NY

2001-2003 Assistant Professor of Medicine, Department of Medicine, Pulmonary, Allergy and Critical

Care Division, Columbia University College of Physicians and Surgeons, New York, NY


6

1998-2001 Assistant Professor of Medicine, Department of Medicine, Pulmonary, Allergy and Critical

Care Division, University of Pennsylvania, Philadelphia, PA

Hospital and Administrative Appointments:

2016- The Transplant Forum, Faculty Committee Member, Columbia University Medical Center,

New York, NY

2016- Inaugural Member, Academy of Clinical Mentoring and Excellence (ACME), Columbia

University Medical Center

2015- Medical Director, 9HN Transplant Unit, Making Care Better Initative, NewYork-

Presbyterian Hospital

2015-16 Member, Taskforce, US News and World Report Committee, NewYork-Presbyterian

Hospital

2013-15 Chair, Lung Transplant Clinical Pathway Committee, NewYork-Presbyterian Hospital

2008- Co-chair, Transplant Subcommittee, Formulary and Therapeutics Committee

2008- Member, Executive Committee of the Department of Medicine, Promotions and Tenures

2008- Attending Physician, Morgan Stanley Children’s Hospital, Columbia University

College of Physicians and Surgeons

2008- Attending Physician, NewYork-Presbyterian Hospital, Columbia University College

of Physicians and Surgeons

2006- Associate Program Director, Pulmonary Fellowship Training Program, Columbia University

College of Physicians and Surgeons, Pulmonary, Allergy and Critical Care Division, New

York, NY

2001- Medical Program Director, Lung Transplantation Program, New York-Presbyterian

Hospital, Columbia University College of Physicians and Surgeons

Foundation, expansion and management of a new lung transplant program that

resulted in Program’s Medicare approval, major growth in staff and patient volume

with 848 transplants surgeries until 12/31/2017 and survival rates significantly

exceeding national UNOS survival

2001-2008 Associate Attending Physician, New York-Presbyterian Hospital, Columbia

University College of Physicians and Surgeons

1999-2001 Associate Director, Pulmonary and Critical Care Fellowship Training Program, University of

Pennsylvania, Philadelphia, PA

1999-2001 Attending Physician, Department of Medicine, Hospital of the University of Pennsylvania

Advanced Lung Disease and Lung Transplantation, Pulmonary Consultation, and Medical

Intensive Care Unit Services, Outpatient Clinic in Pulmonary Medicine and Lung

Transplantation, and Pulmonary Alveolar Proteinosis Program


7

1999-2001 Attending Physician, Department of Medicine, Presbyterian Medical Center, University of

Pennsylvania, Outpatient Clinic in Lung Volume Reduction Surgery Program

Awards, Honors and Membership in Honorary Societies:

2016 Fellow of the American Society of Transplantation (F.A.S.T.)

2002-17 Inclusion in America’s Top Doctors and Top Doctors: New York Metro Area

2009-18 Inclusion in New York City Super Doctors, New York Times Magazine

2002 Fellow of the American College of Physicians (F.A.C.P.)

2001 Fellow of the American College of Chest Physicians (F.C.C.P.)

1990 Rank Valedictorian of class in Ege University School of Medicine

1984 Rank Valedictorian of class in Tarsus American College

Previous Fellowship and Grant Support:

1998 The Role of Transmembrane Mucin MUC1 in Airway Defense Function

National Institutes of Health, National Heart, Lung, and Blood Institute

Research Career Award 1 KO8 HL03820-01, 1998-2003, past, $386,750

1995 Pathogenesis of Airway Disease in Cystic Fibrosis

National Institutes of Health, National Heart, Lung, and Blood Institute

National Research Service Award F32 HL 0957501, 1996-99, past, $95,400

1995 Pathogenesis of Airway Disease in Cystic Fibrosis

American Lung Association

Research Training Fellowship Grant RT-087-N1, 1996-98, past, $65,000

Departmental and University Committees:

2006- Member, Pulmonary and Critical Care Fellowship Selection Committee, Columbia

University

1999-2001 Member, Pulmonary and Critical Care Fellowship Selection Committee, University

of Pennsylvania

1994 Member, Curriculum Committee, State University of New York Health Science

Center at Brooklyn

Teaching Experience and Responsibilities:

University of Pennsylvania School of Medicine


8

Lecturer and facilitator, Pulmonary Module of Curriculum 2000 for second-year medical students

1999-Lecturer, “Interstitial Lung Diseases” and Workshop Facilitator

(3 workshops per year)

2000-Lecturer, “Interstitial Lung Diseases” and Workshop Facilitator


2001- Lecturer, “Interstitial Lung Diseases” and Workshop Facilitator


University of Pennsylvania, Department of Medicine, Graduate Medical Education

Pulmonary and Critical Care Fellowship Training Program

1999-2001 Associate Director

Outpatient Practice Preceptor

1999-2001 2 senior fellows/year, bi-weekly for 6 months

1999-2001 3 medical residents/year, weekly for 1 month

Annual Summer Lecture Series in Pulmonary Medicine

1999- Lecturer, "Thrombolytic Therapy of Pulmonary Embolism" and “Mediastinal

Disorders”

2000- Lecturer, "Thrombolytic Therapy of Pulmonary Embolism" and “Mediastinal

Disorders”

2001-Lecturer, "Treatment of Massive Pulmonary Embolism" and “Mediastinal Disorders”

2001-Organizer of Lecture Series

Supervision of activities and teaching of medical students, house officers and fellows on pulmonary

consultation, advanced lung disease, lung transplantation, and intensive care services

Fellowship Mentoring Program

Pulmonary & Critical Care Fellowship Program, Clinical Mentor

1999-Conrad Reed, M.D.

2000-Pinak Acharya, M.D.

2001-Paul Kinniry, MD

Columbia University College of Physicians and Surgeons, Department of Medicine

Annual Didactic Lecture Series in Pulmonary Medicine

2002- Lecturer, "Lung Transplantation. State-of-the Art" and “Mediastinal Disorders”

2003- Lecturer, "Lung Transplantation"

2004- Lecturer, “Lung Transplantation” and “Management of Life-Threatening Pulmonary

Embolism”

2005- Lecturer, “Lung Transplantation”

2006- Lecturer, “Lung Transplantation” and “Massive Pulmonary Embolism”

2006- Organizer of Didactic Lecture Series

2007- Lecturer, “Lung Transplantation” and “Massive Pulmonary Embolism”



9


2008-Lecturer, “Life-threatening Pulmonary Embolism”, “Lung transplantation”, and

“Diffuse parenchymal lung disease”

2009- Lecturer, “Management of Pulmonary Embolism”, “Lung transplantation Update”,

“Approach to Interstitial Lung Disease”

2010- Lecturer, “Massive Pulmonary Embolism”, “Lung transplantation. 2010 State-of-the-

Art ”

2011- Lecturer, “Massive Pulmonary Embolism”, “Overview of lung transplantation ”

2012- Lecturer, “Management of Life Threatening Pulmonary Embolism” and “Lung

Transplantation ”

2013- Lecturer, “Management of Life Threatening Pulmonary Embolism” and “Lung

Transplantation ”

2014- Lecturer, “Management of Life Threatening Pulmonary Embolism” and “Updates in

Lung Transplantation ”

2015- Lecturer, “Overview of Lung transplantation in 2015”

2016- Lecturer, “Update on Lung Transplantation”

2017- Lecturer, “Lung Transplantation. Sicker Patients, Improving Outcomes in 2017”

Morning Reports and Chief of Service Rounds for Medical House staff 2001-17

Teaching and supervision of visiting fellows for Lung Transplantation Rotation

Monteofiore Medical Center (2002-07)

Lenox Hill Hospital (2002-16)

Memorial Sloan Kettering Cancer Center (2002-08)

New York Methodist Hospital (2004-17)

Yale University (2004)

Supervision of activities and teaching of fellows on the Lung Transplantation in-patient Service, out-

patient practice and bronchoscopy (2001-2017)

Fellowship Mentoring Program, Clinical Mentorship

2001-03 Jessie Wilt, M.D.

2002-05 Lori Shah, M.D.

2003-06 David Lederer, M.D.

2006-08 Claire Keating, M.D.

2006-10 Hilary Robbins, M.D.

2011-12 Jamie Hook, M.D.

2014-16 Luke Benvenuto, MD

Pulmonary and Critical Care Fellowship Training Program

2006-08 Associate Program Director

Founder and Organizer, Pulmonary/CCM Fellow Mentoring Program 2006-08 academic years

Organizer, Pulmonary Grand Rounds 2006-07: Identification, invitation and scheduling of speakers

Physical Diagnosis Course for Second Year Medical Students 2006-07

Pulmonary Pathophysiology Course 2009, Lecturer, “Pulmonary Vascular Disease. Pulmonary

Hypertension and Pulmonary Embolism”


10

Pulmonary Pathophysiology Course 2010, Lecturer, “Pulmonary Hypertension” and “Pulmonary

Embolism”

The Body in Health and Disease” Course 2011, 1st year Medical School, Lecturer, “Pulmonary

Embolism”

Other Professional Activities:

Editorial Positions

Inaugural member, Editorial Board of the Annals of the American Thoracic Society (2014-17)

Reviewer, Chest

Reviewer, European Respiratory Journal

Reviewer, Annals of Thoracic Surgery

Reviewer, Transplantation

Reviewer, The Journal of Critical Illness

Reviewer, Annals of Internal Medicine

Reviewer, The Journal of Heart and Lung Transplantation

Reviewer, American Journal of Transplantation

Reviewer, American Journal of Respiratory and Critical Care Medicine

Reviewer, Journal of Thoracic Oncology

International Editorial Board, Turkish Thoracic Journal

Guest Editor, Section on Lung Transplantation, In Current Opinion in Organ Transplantation,

L.S. Sher, D. Cramer, J.M. Grinyo (Eds.) 2009;14:463-503.

Clinical Research Activities:

Current:

Principal investigator: Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis

Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts (CAG-00324R2).

This is a multi-center clinical registry to assess the efficacy and safety of photopheresis.

Sponsor: Center for Medicare and Medicaid Services and Therakos

New York-Presbyterian Hospital, Columbia University College of Physicians and Surgeons

Co-investigator: NOVEL Lung Trial: Normothermic Ex Vivo Lung Perfusion (EVLP) As An Assessment

of Extended/Marginal Donor Lungs. Sponsor: Vitro Life, Inc. (CU Principal Investigator: Frank D’Ovidio)

Co-investigator: Protocol number: SHP620-303. A Phase 3, Multicenter, Randomized, Open-label,

Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to

Investigator-assigned Treatment in Transplant Recipients with Cytomegalovirus (CMV) Infections that

are Refractory or Resistant to Treatment with Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir.

Sponsor: Shire ViroPharma, Inc. (CU Principal Investigator: Marcus Pereira)

Past:


11

Principal investigator: A Multi-center, Multinational, Randomized, Double-blind, Placebo-controlled

Study to Evaluate the Efficacy and Safety of Aerosolized ALN-RSV01 Plus Standard of Care in Lung

Transplant Patients Infected With Respiratory Syncytial Virus (RSV).

Sponsor: Alnylam Pharmaceuticals


Co-investigator: BIBF 1120. A 52-week, Double-blind, Randomized, Placebo-controlled Trial Evaluating

the Effect of Oral BIBF 1120, 150 mg twice daily, on Annual Forced Vital capacity Decline In Patients

with Idiopathic Pulmonary Fibrosis. Sponsor: Boehringer Ingelheim. (Principal Investigator: David

Lederer)

Principal Investigator: CIS001: A Multi-center, Randomized, Controlled Study to Demonstrate the

Efficacy and Safety and Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans

Syndrome-Free Survival Following Lung Transplantation. Sponsor: APT Pharmaceuticals, Inc.


Principal Investigator: CIS002: An Open-Label, Multi-Center, Extension Study of Cyclosporine

Inhalation Solution in Subjects Previously Enrolled in the APT Study CIS001. Sponsor: APT

Pharmaceuticals, Inc.


Co-investigator: ARTEMIS: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center,

Parallel-Group, Event-Driven Study to Evaluate the Efficacy and Safety of Ambrisentan in Subjects with

Early Idiopathic Pulmonary Fibrosis (IPF). Sponsor: Gilead


Co-investigator: Correlation of Donor Proinflammatory mRNA Profiles with Early Outcomes of Thoracic

and Abdominal Transplantation. CTOT-3. Sponsor: NIH


Co-investigator: PIPF-012. An Open Label Extension Study of the Long Term Safety of Pirfenidone in

Patients with Idiopathic Pulmonary Fibrosis (IPF) Who Complete the CAPACITY Studies Sponsor.

Intermune, Inc.


Co-investigator: National Emphysema Treatment Trial (NETT): Multicenter, Randomized, Controlled

Trial of Lung Volume Reduction Surgery for Emphysema

Hospital of the University of Pennsylvania

Co-investigator: Multicenter, Randomized, Placebo-controlled Clinical Trial of Interferon- for Treatment

of Idiopathic Pulmonary Fibrosis


Co-investigator: Multicenter, Randomized, Placebo-controlled Trial of GM-CSF for Alveolar Proteinosis.

Grant funded by the FDA Orphan Products Development Program.


Collaborator: Gene expression microarrays in lung rejection. Principal Investigator: Marshall Hertz

Sponsor: National Institute of Allergy and Infectious Diseases, 1 PO1 AI50162-01.


12

Co-investigator: A Multicenter Prospective Cohort Study Examining The Role of Protein C (Activated) in

Lung Injury Following Lung Transplantation sponsored by Eli Lilly and Company


Principal Investigator: IGIV treatment for acquired immunodeficiency in lung transplant patients: A

randomized cross-over trial. Talecris, Biological Products Division


Co-Principal Investigator: Lung allograft rejection gene expression observational (LARGO) study: A

multicenter study. Sponsor: XDx Expression Diagnostics


Principal Investigator: Outcomes of tacrolimus/imuran versus cyclosporine/mycophenolate mofetil

therapy with IL-2 antagonist induction therapy following lung transplantation. Sponsor: Astellas Inc.


Co-Investigator: Comparison of a Tacrolimus/Sirolimus/Prednisone Regimen versus

Tacrolimus/Azathioprine/Prednisone Immunosuppressive Regimen in Lung Transplantation. A

multicenter, controlled, randomized trial sponsored by Loyola University Medical Center and Fujisawa

Healthcare, Inc.


Co-investigator: Phase II Study of Inhaled Carbon Monoxide for the Treatment of IPF

The purpose of this study is test the safety and efficacy of inhaled carbon monoxide in IPF

Grant: NIH/NHLBI U01 HL105371 (Principal Investigator: A. Choi)

Project period: 03/01/2012 – 06/30/2014

Co-investigator: PIPF-016. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the

Efficacy and Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. Sponsor: Intermune.

(Principal Investigator: Nina Patel)

Co-investigator: Explaining Racial and Ethnic Disparities in Idiopathic Pulmonary Fibrosis

(Principal Investigator: David J. Lederer)

Grant Number: 1 K23 HL086714-01A2

Project Period: 04/01/08-03/31/12

Co-Investigator: Genetics of Primary Graft Dysfunction

(Principal Investigator: J. Christie)

Grant Number: R01 HL081619 NIH/NHLBI

Project period: 02/15/2007 – 01/31/2012

NIH/NHLBI

Co-Investigator: Clinical Risk Factors for Primary Graft Dysfunction

(Principal Investigator: J. Christie)

Grant Number: R01 HL087115 NIH/NHLBI

Project period: 08/15/2007 – 07/31/2012

Co-investigator: A Phase 2, Randomized, Dose Ranging Study to Evaluate the Efficacy of Tralokinumab in

Adults with Idiopathic Pulmonary Fibrosis

This is a multicenter clinical trial of tralokinumab (an IL-13 antagonist) to treat IPF.

Grant: MedImmune CD-RI-CAT-354-1066


13

Project period: 12/04/2012 - 12/31/2015

Bibliography:

Original, peer reviewed articles:

S.M. Arcasoy, J.D. Latoche, M. Gondor, R.A. Henderson, R. Hughey, O.J. Finn, J.M. Pilewski.

MUC1 and other sialoglycoconjugates inhibit adenovirus-mediated gene transfer to

epithelial cells. Am J Respir Cell Mol Biol 1997;17:422-35.*

S.M. Arcasoy, J.D. Latoche, M. Gondor, B.R. Pitt, J.M. Pilewski. Polycations increase the

efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro.

Gene Therapy 1997;4:32-38.*

S.M. Arcasoy, J.D. Latoche, M. Gondor, R.A. Henderson, R. Hughey, O.J. Finn, J.M. Pilewski.

The effects of sialoglycoconjugates on adenovirus-mediated gene transfer to epithelial cells

in vitro and in human airway xenografts. Chest 1997;111:142S-3S.*

J.M. Pilewski, J.D. Latoche, S.M. Arcasoy, S.M. Albelda. Expression of integrin cell adhesion

receptors during human airway epithelial repair in vivo. Am J Physiol (Lung Cell Mol

Physiol 17) 1997;273:L256-63.

S.M. Arcasoy, J.R. Jett. Superior pulmonary sulcus tumors and the Pancoast’s syndrome. N Engl

J Med 1997;337:1370-6. *

S.M. Arcasoy, J.W. Kreit. Thrombolytic therapy of pulmonary embolism: a comprehensive review

of current evidence. Chest 1999;115:1695-1707. *

S.M. Arcasoy, R.M. Kotloff. Lung transplantation. N Engl J Med 1999;340:1081-91.*

A. Pochettino, R.M. Kotloff, B.R. Rosengard, S.M. Arcasoy, N.P. Blumenthal, L.R. Kaiser, J.E.

Bavaria. Bilateral versus single lung transplantation for chronic obstructive pulmonary

disease: Intermediate-term results. Ann Thorac Surg 2000;70:1813-9.

S.M. Arcasoy, C. Hersh, J.D. Christie, D. Zisman, A. Pochettino, B.R. Rosengard, N.P. Blumenthal,

H.I. Palevsky, J.E. Bavaria, R.M. Kotloff. Bronchogenic carcinoma Complicating Lung

Transplantation. J Heart Lung Transplant 2001;20:1044-53. *

S.M. Arcasoy, J.D. Christie, A. Pochettino, B.R. Rosengard, N.P. Blumenthal, J.E. Bavaria, R.M.

Kotloff. Characteristics and Outcomes of Patients with Sarcoidosis Listed for Lung

Transplantation. Chest 2001;120:873-80. *

R.M. Kotloff, J. Hansen-Flaschen, D.A. Lipson, G. Tino, S.M. Arcasoy, A. Alavi, L.R. Kaiser.

Apical Perfusion Fraction as a Predictor of Short Term Functional Outcome Following

Bilateral Lung Volume Reduction Surgery. Chest 2001;120:1609-15.

W.Y. Szeto, D. Kreisel, G.C. Karakousis, A. Pochettino, D.H. Sterman, R.M. Kotloff, S.M.

Arcasoy, D.A. Zisman, N.P. Blumenthal, R.J. Gallop, L.R. Kaiser, J.E. Bavaria, B.R.

Rosengard. Cardiopulmonary bypass for bilateral sequential lung transplantation in

patients with chronic obstructive pulmonary disease without adverse effect on lung

function or clinical outcome. J Thorac Cardiovasc Surg 2002;124(2):241-9.


14

A.M. Krasinskas, D. Kreisel, M.A. Acker, J.E. Bavaria, A. Pochettino, R.M. Kotloff, S. Arcasoy,

N. Blumenthal, M. Kamoun, J.S. Moore, B.R. Rosengard. CD3 monitoring of

antithymocyte globulin therapy in thoracic organ transplantation. Transplantation

2002;73:1339-41.

S.M. Arcasoy, J.D. Christie, V.A. Ferrari, M. St. John Sutton, D.A. Zisman, N.P. Blumenthal, A.

Pochettino, R.M. Kotloff. Echocardiographic assessment of pulmonary hypertension in

patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-40. *

J.D. Christie, R.M. Kotloff, A. Pochettino, S.M. Arcasoy, B.R. Rosengard, J.R. Landis, S.E.

Kimmel. Clinical Risk Factors for Primary Graft Failure Following Lung Transplantation.

Chest 2003;124:1232-41.

J.R. Kizer, D.A. Zisman, N.P. Blumenthal, R.M. Kotloff, S.E. Kimmel, R. M. Strieter, S.M. Arcasoy,

V.A. Ferrari, J. Hansen-Flaschen. Association Between Pulmonary Fibrosis and Coronary Artery

Disease. Arch Intern Med 2004;164:551-6.

M.E. Bowdish, S.M. Arcasoy, J.S. Wilt, J.V. Conte, R.D. Davis, E.R. Garrity, M.L. Hertz, J.B. Orens,

B.R. Rosengard, M.L. Barr. Surrogate markers and risk factors for lung allograft dysfunction. Am

J Transplant 2004;4:1171-8.

S.M. Kawut, A. Reyentovich, J.S. Wilt, R. Anzeck, D.J. Lederer, M.K. O’Shea, J.R. Sonett, S.M.

Arcasoy. Outcomes of extended donor lung transplant recipients after lung

transplantation. Transplantation 2005;79:310-6.*

S.M. Kawut, L. Shah, J.S. Wilt, E. Dwyer, P.A. Maani, T.H. Daly, M.K. O’Shea, J.R. Sonett,

S.M. Arcasoy. Risk Factors and Outcomes of Hypogammaglobulinemia After Lung

Transplantation. Transplantation 2005;79:1723-6.*

S.M. Arcasoy, A. Fisher, R.R. Hachem, M. Scavuzzo, L.B. Ware. Report of the ISHLT Working

Group on Primary Lung Graft Dysfunction. Part V: Predictors and Outcomes. J Heart

Lung Transplant 2005;24:1483-8. *

J.D. Christie, D. Van Raemdonck, M. de Perrot, M. Barr, S. Keshavjee, S.M. Arcasoy, J.

Orens. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction: Part I:

Introduction and Methods. J Heart Lung Transplant 2005;24:1451-3.

S.M. Kawut, M.K. O’Shea, M.N. Bartels, J.S. Wilt, J.R. Sonett, S.M. Arcasoy. Exercise testing

determines survival in patients with diffuse parenchymal lung disease evaluated for lung

transplantation. Respir Med 2005;99:1431-9.*

C.E. Caplan-Shaw, S.M. Arcasoy, E. Shane, D.J. Lederer, J.S. Wilt, M.K. O'Shea, V. Addesso, J.R.

Sonett, S.M. Kawut. Osteoporosis in diffuse parenchymal lung disease. Chest

2006;129:140-6.

D.J. Lederer, C.E. Caplan-Shaw, M.K. O'Shea, J.S. Wilt, R.C. Basner, M.N. Bartels, J.R. Sonett,

S.M. Arcasoy, S.M. Kawut. Racial and ethnic disparities in survival in lung transplant

candidates with idiopathic pulmonary fibrosis. Am J Transplant 2006;6:398-403.


15

N.H. Yip, D.J. Lederer, S.M. Kawut, J.S. Wilt, F. D'Ovidio, Y. Wang, E. Dwyer, J.R. Sonett,

S.M. Arcasoy. Immunoglobulin G Levels Before and After Lung Transplantation. Am J

Respir Crit Care Med 2006; 173:917-21.*

J.B. Orens, M. Estenne, S. Arcasoy, J.V. Conte, P. Corris, J.J. Egan, T. Egan, S. Keshvajee, C.

Knoop, R. Kotloff, F.J. Martinez, S. Nathan, S. Palmer, A. Patterson, L. Singer, G. Snell,

S. Studer, J.L. Vachiery, A.R. Glanville. International Guidelines for the Selection of

Lung Transplant Candidates: 2006 Update. J Heart Lung Transplant 2006;25:745-55.

D.J. Lederer, S.M. Arcasoy, J.S. Wilt, F. D'Ovidio, J.R. Sonett, S.M. Kawut. Six-minute Walk

Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis. Am J Respir

Crit Care Med 2006;174:659-64.

D.J. Lederer, S.M. Arcasoy, R.G. Barr, J.S. Wilt, E. Bagiella, F. D'Ovidio, J.R. Sonett, S.M.

Kawut SM. Racial and Ethnic Disparities in Idiopathic Pulmonary Fibrosis: A

UNOS/OPTN Database Analysis. Am J Transplant 2006;6:2436-42.

H.A. Yegen, D.J. Lederer, R.G. Barr, J.S. Wilt, Y. Fang, E. Bagiella, F. D'Ovidio, J.M. Okun,

J.R. Sonett JR, S.M. Arcasoy, S.M. Kawut. Risk Factors for Venous Thromboembolism

after Lung Transplantation. Chest 2007;132:547-53.

M.J. Russo, D.I. Sternberg, K.N. Hong, R.A. Sorabella, A.J. Moskowitz, A.C. Gelijns, J.R. Wilt,

F. D'Ovidio, S. Kawut, S. Arcasoy, J.R. Sonett. Post-lung transplant survival is

equivalent regardless of CMV-match status: an Analysis of the United Network for

Organ Sharing database. Ann Thorac Surg 2007;84:1129-35.

A.M. Assaad, S.M. Kawut, S.M. Arcasoy, E.B. Rosenzweig, J.S. Wilt, J.R. Sonett, A.C. Borczuk.

Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis.

Chest 2007;131:850-5.

S.M. Kawut, D.J. Lederer, S. Keshavjii, J.S. Wilt, T. Daly, F. D’Ovidio, J.R. Sonett, S.M.

Arcasoy, M.L. Barr. Outcomes of lung retransplantation in the modern era. Am J Respir

Crit Care Med; 2008:177:114-120.

.

D.J. Lederer, E.K.T Benn, R.G. Barr, J.S. Wilt, G. Reilly, J.R. Sonett, S.M. Arcasoy, S.M.

Kawut. Racial Differences in Waiting List Outcomes in Chronic Obstructive Pulmonary

Disease. Am J Respir Crit Care Med; 2008;177:450-4.

.

D.I. Sternberg, D. Shimbo, S.M. Kawut, J. Sarkar, G. Hurlitz, F. D'Ovidio, D.J. Lederer, J.S.

Wilt, S.M. Arcasoy, D.J. Pinsky, J.M. D'Armiento, J.R. Sonett. Platelet activation in the

postoperative period after lung transplantation. J Thorac Cardiovasc Surg 2008;135:679-

84.

N. Al-Naamani, O.H. Maarouf, J.S. Wilt, M. Bacchetta, F. D'Ovidio, J.R. Sonett, S.M. Arcasoy,

D.J. Lederer, T.L. Nickolas, S.M. Kawut. The Modification of Diet in Renal Disease

(MDRD) and the prediction of kidney outcomes after lung transplantation. J Heart Lung

Transplant 2008;27:1191-7.

N. Al-Naamani, O.H. Maarouf, V.N. Ahya, D.J. Lederer, J.D. Mendez, J.S. Wilt, A.M. Doyle, D.

Rybak, F. D’Ovidio, J.R. Sonett, S.M. Arcasoy, T.L. Nickolas, S.M. Kawut. Assessment


16

of kidney function in lung transplant candidates. J Heart Lung Transplant 2008;27:635-

41.

D.I. Sternberg, R. Gowda, D. Mehra, W. Qu, A. Weinberg, W. Twaddell, J. Sarkar, A. Wallace,

B. Hudson, F. D'Ovidio, S. Arcasoy, R. Ramasamy, J. D'Armiento, A.M. Schmidt, J.R.

Sonett. Blockade of receptor for advanced glycation end product attenuates pulmonary

reperfusion injury in mice. J Thorac Cardiovasc Surg 2008;136: 1576-85.

A. Iribarne, M.J. Russo, R.R. Davies, K.N. Hong, A.C. Gelijns, M.D. Bacchetta, F. D'Ovidio, S.

Arcasoy, J.R. Sonett. Despite Decreased Wait-List Times for Lung Transplantation, Lung

Allocation Scores Continue to Increase. Chest 2009;135(4):923-8.

M.R. Celik, D.J. Lederer, J. Wilt, D. Eser, M. Bacchetta, F. D'Ovidio, J.R. Sonett, S.M. Arcasoy.

Tacrolimus and Azathioprine versus Cyclosporine and Mycophenolate Mofetil after Lung

Transplantation: A Retrospective Cohort Study. J Heart Lung Transplant 2009;28:697-

703.*

D.J. Lederer, J.S. Wilt, F. D'Ovidio, M.D. Bacchetta, L. Shah, S. Ravichandran, J. Lenoir, B. Klein,

J.R. Sonett, S.M. Arcasoy. Obesity and Underweight are Associated with an Increased Risk

of Death after Lung Transplantation. Am J Respir Crit Care Med 2009;180:887-95.*

M.J. Russo, R.R. Davies, K.N. Hong, A. Iribarne, S. Kawut, M. Bacchetta, F. D'Ovidio, S.

Arcasoy, J.R. Sonett. Who is the high-risk recipient? Predicting mortality after lung

transplantation using pretransplant risk factors. J Thorac Cardiovasc Surg 2009;138

1234-8.

M.J. Russo, A. Iribarne, K.N. Hong, R.R. Davies, S. Xydas, H. Takayama, A. Ibrahimiye, A.C.

Gelijns, M.D. Bacchetta, F. D'Ovidio, S. Arcasoy, J.R. Sonett. High Lung Allocation

Score is Associated with Increased Morbidity and Mortality Following Transplantation.

Chest 2010;137:651-7.

V.N. Ahya, P.J. McShane, M.A. Baz, V.G. Valentine, S.M. Arcasoy, R.B. Love, H. Seethamraju,

E. Garrity, C.G. Alex, R. Bag, N.C. DeOliveira, W.T. Vigneswaran, J. Charbeneau, J.A.

Krishnan, R. Durazo-Arvizu, L. Norwick, S. Bhorade. Increased Risk of Venous

Thromboembolism with a Sirolimus Based Immunosuppression Regimen in Lung

Transplantation. J Heart Lung Transplant 2011;30:175-81.

S. Bhorade, V.N. Ahya, M.A. Baz, V.G.Valentine, S.M. Arcasoy, R.B. Love, H. Seethamraju,

C.G. Alex, R. Bag, N.C. DeOliveira, A.Husain, W.T. Vigneswaran, J. Charbeneau, J.A.

Krishnan,MD, R. Durazo-Arvizu, L. Norwick, E. Garrity. Comparison of Sirolimus to

Azathioprine in a tacrolimus based immunosuppressive regimen in lung transplantation.

Am J Respir Crit Care Med 2011;183:379-87.

S.M. Arcasoy, G. Berry, C.C. Marboe, H.D. Tazelaar, M.R. Zamora, H.J. Wolters, K.C. Fang, , S.

Keshavjee for the LARGO Study Investigators. Pathologic Interpretation of

Transbronchial Biopsy For Acute Rejection of Lung Allograft Is Highly Variable. Am J

Transplant 2011;11:320-8.

M.N. Bartels, H.F. Armstrong, R.E. Gerardo, A.M. Layton, B.O. Emmert-Aronson, J. Sonett, S.

Arcasoy. Evaluation of Pulmonary Function and Exercise Performance by


17

Cardiopulmonary Exercise Testing Before and After Lung Transplantation Chest 2011;

140:1604-11.

D.J. Lamas, S.M. Kawut, E. Bagiella, N. Philip, S.M. Arcasoy, D.J. Lederer. Delayed access and

survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med

2011;184:842-7.

D.J. Lederer, S.M. Kawut, N. Wickersham, C. Winterbottom, S. Bhorade, S.M. Palmer, J. Lee,

J.M. Diamond, K.M. Wille, A. Weinacker, V.N. Lama, M. Crespo, J.B. Orens, J.R.

Sonett JR, S.M. Arcasoy, L.B. Ware, and J.D. Christie for the Lung Transplant

Outcomes Group. Obesity and primary graft dysfunction after lung transplantation: the

LTOG Obesity Study. Am J Respir Crit Care Med 2011;184:1055-61.

J.M. Diamond, D.J. Lederer, S.M. Kawut, J. Lee, V.N. Ahya, S. Bellamy, S.M. Palmer, V.N.

Lama, S. Bhorade, M. Crespo,E. Demissie, J. Sonett, K. Wille, J. Orens, A. Weinacker,

D. Weill, B.A. Kohl, C, Deutschman, S. Arcasoy, A.S. Shah, P.D. Shah, J.A. Belperio,

D. Wilkes, J.M. Reynolds, L.B. Ware, J.D. Christie for the Lung Transplant Outcomes

Group. Elevated Plasma Long Pentraxin-3 Levels and Primary Graft Dysfunction after

Lung Transplantation for Idiopathic Pulmonary Fibrosis. Am J Transplant 2011:11:

2517-22.

J.M. Diamond, N.J. Meyer, R. Feng, M. Rushefski, D.J. Lederer, S.M. Kawut, J.C. Lee, E. Cantu,

R.J. Shah, V.N. Lama, S. Bhorade, M. Crespo, E. Demissie, J. Sonett, K. Wille, J. Orens,

A. Weinacker, D. Weill, S. Arcasoy, P.D. Shah, J.A. Belperio, D. Wilkes, L.B. Ware,

S.M. Palmer, J.D. Christie. Variation in PTX3 is Associated With Primary Graft

Dysfunction After Lung Transplantation. Am J Respir Crit Care Med 2012: 186: 546-

552.

J.L Hook, S.M. Arcasoy, D. Zemmel, M. Bartels, S.M. Kawut, D.J. Lederer. Titrated oxygen

requirement and prognostication in idiopathic pulmonary fibrosis. Eur Respir J

2012;39:359-65.

M.R. Baldwin, S.M. Arcasoy, A. Shah, P.C. Schulze, J. Sze, J.R. Sonett, D.J.

Lederer. Hypoalbuminemia and early mortality after lung transplantation: a cohort

study. Am J Transplant 2012;12:1256-67.

J. Javidfar, D. Brodie, A. Iribarne, J. Jurado, M. LaVelle, K. Brenner, S. Arcasoy, J. Sonett,

M. Bacchetta. Extracorporeal membrane oxygenation as a bridge to lung transplantation

and recovery. J Thorac Cardiovasc Surg 2012;144:716-21.

R.J. Shah, J.M. Diamond, D.J. Lederer, S.M. Arcasoy, E.M. Cantu, E.J. Demissie, S.M. Kawut,

B. Kohl, J.C. Lee, J. Sonett, J.D. Christie, L.B. Ware. Plasma monocyte chemotactic

protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung

transplantation. Transl Res. 2012;160:435-42.

J.M. Diamond, M.K. Porteous, E. Cantu, N.J. Meyer, R.J. Shah, D.J. Lederer, S.M. Kawut, J.

Lee, S. Bellamy, S.M. Palmer, V.N. Lama, S. Bhorade, M. Crespo, E. Demissie, K.

Wille, J. Orens, P.D. Shah,A. Weinacker, D. Weill D, S. Arcasoy, D.S. Wilkes, L.B.

Ware, J.D. Christie for the Lung Transplant outcomes Group. Elevated Plasma

Angiopoietin-2 Levels and Primary Graft Dysfunction after Lung Transplantation. PLoS

ONE 2012;7(12):e51932.doi:10.1371

http://www.ncbi.nlm.nih.gov/pubmed/22989614




18

S.M. Bhorade, A.N. Husain, C. Liao, L. Chuan Li, V.N. Ahya, M.A. Baz, V.G.Valentine, R.B.

Love, H.Seethamraju, C.G. Alex, R. Bag, N.C. DeOliveira, W.T. Vigneswaran, E.R.

Garrity, S.M. Arcasoy. Interobserver variability in grading transbronchial lung biopsies

after lung transplantation. Chest 2013;143:1717-24.

J.M. Diamond, J.C. Lee, S.M. Kawut, R.J. Shah, A.R. Localio, S. Bellamy,D.J. Lederer, E.

Cantu, B.A.Kohl, V.N. Lama, S. Bhorade, M. Crespo, E. Demissie, J. Sonnett, K. Wille,

J. Orens, A.S. Shah, A. Weinacker, S. Arcasoy, P.D. Shah, D.S. Wilkes, L.B. Ware,S.M.

Palmer, J.D. Christie for the Lung Transplant Outcomes Group. Clinical Risk Factors for

Primary Graft Dysfunction after Lung Transplantation. Am J Respir Crit Care Med

2013;187:527-34.

N.M. Patel, S.M. Kawut, S.Jelic, S.M. Arcasoy, D.J. Lederer, A.C. Borczuk. Pulmonary arteriole

gene expression signature in idiopathic pulmonary fibrosis. Eur Resp J 2013;41:1324-30.

B. Ghassemieh, V.N. Ahya, MA Baz, V.G. Valentine, S.M. Arcasoy, R.B. Love, H. Seethamraju,

C.G. Alex, R. Bag, N.C. DeOliveira, W.T. Vigneswaran, J. Charbeneau, E.R. Garrity,

S.M. Bhorade. Decreased incidence of cytomegalovirus infection with sirolimus in a post

hoc randomized, multicenter study in lung transplantation. J Heart Lung Transplant

2013;32(7):701-6.

B. Aramini, C. Kim, S. Diangelo, E. Petersen, D.J. Lederer, L. Shah, H. Robbins, J. Floros, S.M.

Arcasoy, J.R. Sonett, F. D'Ovidio. Donor surfactant protein D (SP-D) polymorphisms are

associated with lung transplant outcome. Am J Transplant 2013;13(8):2130-6.

M.R. Baldwin, E.R. Peterson, I. Easthausen, I. Quintanilla, E. Colago, J.R. Sonett, F. D'Ovidio, J.

Costa, J.M. Diamond, J.D. Christie, S.M. Arcasoy, D.J. Lederer. Donor age and early

graft failure after lung transplantation: a cohort study. Am J Transplant

2013;13(10):2685-95.

R.J.Shah, N. Wickersham, D.J. Lederer, S.M. Palmer, E. Cantu, J.M.Diamond, S.M. Kawut,

V.N.Lama, S. Bhorade, M. Crespo, E. Demissie, J. Sonett, K. Wille, J. Orens, A.

Weinacker, P. Shah, S. Arcasoy, D.S. Wilkes, J.D. Christie, L.B. Ware. Pre-operative

plasma club (clara) cell secretory protein levels are associated with primary graft

dysfunction after lung transplantation. Am J Transplant 2014;14:446-52.

JM Diamond, T Akimova, A Kazi, RJ Shah, E Cantu, R Feng, MH Levine, SM Kawut, NJ

Meyer, JC Lee, WW Hancock, R Aplenc, LB Ware, SM Palmer, S Bhorade, VN Lama,

A Weinacker, J Orens, K Wille, M Crespo, DJ Lederer, S. Arcasoy, Demissie E, Christie

JD; Lung Transplant Outcomes Group. Genetic variation in the prostaglandin E2 pathway

is associated with primary graft dysfunction. Am J Respir Crit Care Med

2014;189(5):567-75.

D.J. Lederer, N. Philip, D. Rybak, S.M. Arcasoy, S.M. Kawut. Intravenous immunoglobulin for

hypogammaglobulinemia after lung transplantation: a randomized crossover trial. PLoS

One. 2014;9(8):e103908.doi:10.1371

JP Singer, ER Peterson, ME Snyder, PP Katz, JA Golden, F D'Ovidio, M Bacchetta, JR Sonett, J

Kukreja, L Shah, H Robbins, K Van Horn, RJ Shah, JM Diamond, N Wickersham, L

Sun, S Hays, SM Arcasoy, SM Palmer, LB Ware, JD Christie, DJ Lederer. Body

http://erj.ersjournals.com/search?author1=Nina+M.+Patel&sortspec=date&submit=Submit

http://erj.ersjournals.com/search?author1=Steven+M.+Kawut&sortspec=date&submit=Submit

http://erj.ersjournals.com/search?author1=Sanja+Jelic&sortspec=date&submit=Submit

http://erj.ersjournals.com/search?author1=Selim+M.+Arcasoy&sortspec=date&submit=Submit

http://erj.ersjournals.com/search?author1=David+J.+Lederer&sortspec=date&submit=Submit

http://erj.ersjournals.com/search?author1=Alain+C.+Borczuk&sortspec=date&submit=Submit













19

composition and mortality after adult lung transplantation in the United States. Am J

Respir Crit Care Med 2014;190(9):1012-21.

E.J. Bernstein, E.R. Peterson, J.L. Sell, F. D'Ovidio, S.M. Arcasoy, J.M. Bathon, D.J. Lederer.

Survival of adults with systemic sclerosis following lung transplantation: a nationwide

cohort study. Arthritis Rheumatol 2015;67(5):1314-22.

JM Diamond, MK Porteous, LJ Roberts, N Wickersham, M Rushefski, SM Kawut, RJ Shah, E

Cantu, DJ Lederer , S Chatterjee, VN Lama, S Bhorade, M Crespo, J McDyer, K Wille, J

Orens, A Weinacker, S Arcasoy, PD Shah, DS Wilkes, C Hage, SM Palmer, L Snyder,

CS Calfee, LB Ware, JD Christie. The relationship between plasma lipid peroxidation

products and primary graft dysfunction after lung transplantation is modified by donor

smoking and reperfusion hyperoxia. J Heart Lung Transplant 2016;35:500-7.

J.L. Sell, M Bacchetta, SB Goldfarb, H Park, PV Heffernan, HA Robbins, L Shah, K Raza, F

D'Ovidio, JR Sonett, SM Arcasoy, DJ Lederer. Short Stature and Access to Lung

Transplantation in the United States. A Cohort Study. Am J Respir Crit Care Med

2016;193(6):681-8.

J.P. Singer, JM Diamond, CJ Gries, J McDonnough, PD Blanc, R Shah, MY Dean, B Hersh, PJ

Wolters, S Tokman, SM Arcasoy, K Ramphal, JR Greenland, N Smith, P Heffernan, L

Shah, P Shrestha, JA Golden, NP Blumenthal, D Huang, J Sonett, S Hays, M Oyster, PP

Katz, H Robbins, M Brown, LE Leard, J Kukreja, M Bacchetta, E Bush, F D'Ovidio, M

Rushefski, K Raza, JD Christie, DJ Lederer. Frailty Phenotypes, Disability, and

Outcomes in Adult Candidates for Lung Transplantation. Am J Respir Crit Care Med

2015;192(11):1325-34.

J. Costa, S. Sreekanth, A. Kossar, K. Raza, D.J. Lederer, H. Robbins, L. Shah, J.R. Sonett, S.

Arcasoy, F. D'Ovidio. Donor lung assessment using selective pulmonary vein gases. Eur

J Cardiothorac Surg 2016;50:826-31. PMID: 27242362

J. Costa, S. Sreekanth, A. Kossar, K. Raza, H. Robbins, L. Shah, J.R. Sonett, S. Arcasoy, F.

D'Ovidio. Donors with a prior history of cardiac surgery are a viable source of lung

allografts. Eur J Cardiothorac Surg 2016;50:822-25. PMID: 27147626

J. Gottlieb, M.R. Zamora, T. Hodges, A.W. Musk, U. Sommerwerk, D. Dilling, S. Arcasoy, J.

DeVincenzo, V. Karsten, S. Shah, B.R. Bettencourt, J. Cehelsky, S. Nochur, J. Gollob, A.

Vaishnaw, A.R. Simon, A.R. Glanville. ALN-RSV01 for prevention of bronchiolitis

obliterans syndrome after respiratory syncytial virus infection in lung transplant

recipients. J Heart Lung Transplant 2016 Feb;35(2):213-21.

J.M. Diamond, E. Cantu, M.K. Porteous, Y. Suzuki, K.C. Meyer, D. Lederer, S. Arcasoy, F.

D'Ovidio, M. Bacchetta, J.R. Sonett, G. Singh, J. Costa, J.W. Tobias, H. Rodriguez, V.M.

Van Deerlin , K.M. Olthoff , A. Shaked, B.L. Chang, J.D. Christie; Clinical Trials in

Organ Transplantation (CTOT)-03 Investigators. Peripheral Blood Gene Expression

Changes Associated with Primary Graft Dysfunction after Lung Transplantation Journal

Title: American Journal of Transplantation. Am J Transplant 2017; DOI:

10.1111/ajt.14209














https://www.ncbi.nlm.nih.gov/pubmed/?term=Cantu%20E%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Porteous%20MK%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Suzuki%20Y%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Meyer%20KC%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Lederer%20DJ%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Arcasoy%20S%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=D'Ovidio%20F%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Bacchetta%20M%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Sonett%20JR%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Singh%20G%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Costa%20J%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Tobias%20JW%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Rodriguez%20H%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Van%20Deerlin%20VM%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Olthoff%20KM%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Shaked%20A%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Chang%20BL%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Christie%20JD%5BAuthor%5D&cauthor=true&cauthor_uid=28117940

https://www.ncbi.nlm.nih.gov/pubmed/?term=Clinical%20Trials%20in%20Organ%20Transplantation%20(CTOT)-03%20Investigators%5BCorporate%20Author%5D

https://www.ncbi.nlm.nih.gov/pubmed/?term=Clinical%20Trials%20in%20Organ%20Transplantation%20(CTOT)-03%20Investigators%5BCorporate%20Author%5D


20

J.M. Diamond, S. Arcasoy, J.A. McDonnough, J.R. Sonett, M. Bacchetta, F. D'Ovidio, E. Cantu

3rd, C.A. Bermudez, A. McBurnie, M. Rushefski, L.H. Kalman, M. Oyster, C. D'Errico,

Y. Suzuki, J.T. Giles, A. Ferrante, M. Lippel, G. Singh, D.J. Lederer, J.D. Christie; Lung

Transplant Body Composition Study. Adipose Gene Expression Profile Changes With

Lung Allograft Reperfusion. Am J Transplant 2017 Jan;17(1):239-245. PMID: 27421969

A.M. Layton, H.F. Armstrong, H.P. Kim, K.S. Meza, F. D’Ovidio, S.M. Arcasoy.

Cardiopulmonary exercise factors predict survival in patients with advanced interstitial

lung disease referred for lung transplantation. Respir Med 2017; 126: 59-67

M.K. Porteous, J.C. Lee, D.J. Lederer, S.M. Palmer, E. Cantu, R.J. Shah, S.L. Bellamy, V.N.

Lama, S.M. Bhorade, M.M. Crespo, J.F. McDyer, K.M. Wille, A.R. Localio, J.B. Orens,

P.D. Shah, A.B. Weinacker, S. Arcasoy, D.S. Wilkes, L.B. Ware, J.D. Christie, S.M.

Kawut, J.M. Diamond JM; Lung Transplant Outcomes Group. Clinical Risk Factors and

Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients

with Pulmonary Hypertension. Ann Am Thorac Soc 2017 Jul 18. doi:

10.1513/AnnalsATS.201610-810OC. [Epub ahead of print]. PMID: 28719755

M.R. Baldwin, J.P. Singer, D. Huang, J. Sell, W.C. Gonzalez, L.R. Pollack, M.S. Maurer, F.F.

D'Ovidio, M. Bacchetta, J.R. Sonett, S.M. Arcasoy, L. Shah, H. Robbins, S.R. Hays, J.

Kukreja, J.R. Greenland, R.J. Shah, L. Leard, M. Morrell, C. Gries, P.P. Katz, J.D.

Christie, J.M. Diamond, D.J. Lederer DJ. Refining Low Physical Activity Measurement

Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical Illness.

Ann Am Thorac Soc 2017 Aug;14(8):1270-1279. doi: 10.1513/AnnalsATS.201612-

1008OC. PMID:28398076

L.J. Benvenuto, D.R. Anderson, H.P. Kim, J.L. Hook, L. Shah, H.Y. Robbins, F. D’Ovidio, M.

Bacchetta, J.R. Sonett, S.M. Arcasoy. Geographic disparities in donor lung supply and

lung transplant waitlist outcomes: A Cohort Study. Am J Transplant 2018; 18:1471-80

Authors. Frailty phenotypes and mortality after lung transplantation: a prospective cohort study.

Am J Transplant; 2018: DOI: 10.1111/ajt.14873

Contributions to Peer-reviewed Publications not Cited by Authorship

National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-

volume-reduction surgery. N Engl J Med 2001;345:1075-83.

Cost Effectiveness of Lung-Volume-Reduction Surgery for Patients with Severe Emphysema

National Emphysema Treatment Trial Research Group. N Engl J Med 2003;348:2092-

102.

A Randomized Trial Comparing Lung-Volume–Reduction Surgery with Medical Therapy for

Severe Emphysema. National Emphysema Treatment Trial Research Group. N Engl J

Med 2003;348:2059-73.

R.M. Kaplan, A.L. Ries, J. Reilly, Z. Mohsenifar; National Emphysema Treatment Trial Research

Group. Measurement of health-related quality of life in the national emphysema

treatment trial. Chest 2004 Sep;126:781-9.

https://www.ncbi.nlm.nih.gov/pubmed/27421969







https://doi.org/10.1111/ajt.14873

http://content.nejm.org/cgi/content/short/348/21/2092






21

S.M. Lee, R. Wise, A.L. Sternberg, J. Tonascia, S. Piantadosi; National Emphysema Treatment

Trial Research Group. Methodologic issues in terminating enrollment of a subgroup of

patients in a multicenter randomized trial. Clin Trials 2004;1:326-38.

A.L. Ries, B.J. Make, S.M. Lee, M.J. Krasna, M. Bartels, R. Crouch, A.P. Fishman; National

Emphysema Treatment Trial Research Group. The effects of pulmonary rehabilitation in

the national emphysema treatment trial. Chest 2005 Dec;128:3799-809.

L.B. Herpel, R.E. Kanner, S.M. Lee, H.E. Fessler, F.C. Sciurba, J.E. Connett, R.A. Wise;

National Emphysema Treatment Trial Research Group. Variability of spirometry in

chronic obstructive pulmonary disease: results from two clinical trials. Am J Respir Crit

Care Med 2006;173:1106-13.

F.J Martinez, G. Foster, J.L. Curtis, G. Criner, G. Weinmann, A. Fishman, M.M. DeCamp, J.

Benditt, F. Sciurba, B. Make, Z. Mohsenifar, P. Diaz, E. Hoffman, R. Wise; NETT

Research Group. Predictors of mortality in patients with emphysema and severe airflow

obstruction. Am J Respir Crit Care Med 2006;173:1326-34.

M.M. DeCamp, E.H. Blackstone, K.S. Naunheim, M.J. Krasna, D.E. Wood, Y.M. Meli, R.J.

McKenna Jr; NETT Research Group. Patient and surgical factors influencing air leak

after lung volume reduction surgery: lessons learned from the National Emphysema

Treatment Trial. Ann Thorac Surg 2006;82:197-206.

W.M. Chatila, E.A. Hoffman, J. Gaughan, G.B. Robinswood, G.J. Criner; National Emphysema

Treatment Trial Research Group. Advanced emphysema in African-American and white

patients: do differences exist? Chest 2006 Jul;130:108-18.

J.D. Christie, N. Robinson, L.B. Ware, M. Plotnick, J. DeAndrade, V. Lama, A. Milstone,

J. Orens, A. Weinacker, E. Demissie, S. Bellamy, S.M. Kawut for the Lung Transplant

Outcomes Group. Association of protein C and type-1 plasminogen activator inhibitor

with primary graft dysfunction. Am J Resp Crit Care Med 2007;175:69-74.

KS Naunheim, DE Wood, Z Mohsenifar, AL Sternberg, GJ Criner, MM DeCamp, CC

Deschamps, FJ Martinez, FC Sciurba, J Tonascia, AP Fishman; National Emphysema

Treatment Trial Research Group. Long-term follow-up of patients receiving lung-

volume-reduction surgery versus medical therapy for severe emphysema by the National

Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006;82:431-43.

JK Stoller, TR Gildea, AL Ries, YM Meli, MT Karafa; National Emphysema Treatment Trial

Research Group. Lung volume reduction surgery in patients with emphysema and alpha-1

antitrypsin deficiency. Ann Thorac Surg 2007;83:241-51.

GJ Criner, SM Scharf, JA Falk, JP Gaughan, AL Sternberg, NB Patel, HE Fessler, OA Minai, AP

Fishman; National Emphysema Treatment Trial Research Group. Effect of lung volume

reduction surgery on resting pulmonary hemodynamics in severe emphysema. Am J

Respir Crit Care Med 2007;176(3):253-60.

F.J. Martinez, M.K. Han, A.C. Andrei, R. Wise, S. Murray, J.L. Curtis, A. Sternberg, G. Criner,

S.E. Gay, J. Reilly, B. Make, A.L. Ries, F. Sciurba, G. Weinmann, Z. Mosenifar, M.

DeCamp, A.P. Fishman, B.R. Celli; National Emphysema Treatment Trial Research





















http://www.ncbi.nlm.nih.gov/pubmed/18535255?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum




22

Group. Longitudinal change in the BODE index predicts mortality in severe emphysema.

Am J Respir Crit Care Med 2008;178:491-9

M.B. Drummond, A.L. Blackford, J.O. Benditt, B.J. Make, F.C. Sciurba, M.C. McCormack, F.J.

Martinez, H.E. Fessler, A.P. Fishman, R.A. Wise; NETT Investigators. Continuous

oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of

patients: retrospective analysis of the national emphysema treatment trial. Chest

2008;134:497-506.

MR Fisher, GJ Criner, AP Fishman, PM Hassoun, OA Minai, SM Scharf, HE Fessler; NETT

Research Group. Estimating pulmonary artery pressures by echocardiography in patients

with emphysema. Eur Respir J 2007;30:914-21.

VS Fan, SD Ramsey, ND Giardino, BJ Make, CF Emery, PT Diaz, JO Benditt, Z Mosenifar, R

McKenna Jr, JL Curtis, AP Fishman, FJ Martinez; National Emphysema Treatment Trial

(NETT) Research Group. Sex, depression, and risk of hospitalization and mortality in

chronic obstructive pulmonary disease. Arch Intern Med 2007 Nov 26;167:2345-53.

V.S. Fan, N.D. Giardino, D.K. Blough, R.M. Kaplan, S.D. Ramsey; Nett Research Group. Costs

of pulmonary rehabilitation and predictors of adherence in the National Emphysema

Treatment Trial. COPD 2008;5:105

M.L. Snyder, C.H. Goss, B. Neradilek, N.L. Polissar, Z. Mosenifar, R.A. Wise, A.P. Fishman,

J.O. Benditt; National Emphysema Treatment Trial Research Group. Changes in arterial

oxygenation and self-reported oxygen use after lung volume reduction surgery. Am J

Respir Crit Care Med 2008;178:339-45.

C.D. Brown, J.O. Benditt, F.C. Sciurba, S.M. Lee, G.J. Criner, Z. Mosenifar, D.M. Shade, W.A.

Slivka, R.A. Wise; National emphysema Treatment Trial Research Group. Exercise

testing in severe emphysema: association with quality of life and lung function. COPD

2008;5:117-24.

F.J. Martinez, J.L. Curtis, F. Sciurba, J. Mumford, N.D. Giardino, G. Weinmann, E. Kazerooni, S.

Murray, G.J. Criner, D.D. Sin, J. Hogg, A.L. Ries, M. Han, A.P. Fishman, B. Make, E.A.

Hoffman, Z. Mohsenifar, R. Wise; National Emphysema Treatment Trial Research

Group. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med

2007;176(3):243-52.

G.R. Washko, V.S. Fan, S.D. Ramsey, Z. Mohsenifar, F. Martinez, B.J. Make, F.C. Sciurba, G.J.

Criner, O. Minai, M.M. Decamp, J.J. Reilly; National Emphysema Treatment Trial

Research Group. The effect of lung volume reduction surgery on chronic obstructive

pulmonary disease exacerbations. Am J Respir Crit Care Med 2008;177:164-9.

S.M. Kawut, J. Okun, D. Shimbo, D.J. Lederer, J. De Andrade, V. Lama, A. Shah, A. Milstone,

L.B. Ware, A. Weinacker, E. Demissie, J.D. Christie, and for the Lung Transplant

Outcomes Group. Chest 2009;136 237-44.

G.R. Washko, F.J. Martinez, E.A. Hoffman, S.H. Loring, R.S. Estépar, A.A. Diaz, F.C. Sciurba,

E.K. Silverman, M.K. Han, M. Decamp, J.J. Reilly; National Emphysema Treatment

Trial Research Group. Physiological and computed tomographic predictors of outcome

from lung volume reduction surgery. Am J Respir Crit Care Med 2010;181:494-500.



















23

J.D. Christie, C.V. Shah, S.M. Kawut, N. Mangalmurti, D.J. Lederer, J.R. Sonett, V.N. Ahya,

S.M. Palmer, K. Wille, V. Lama, P.D. Shah, A. Shah, A. Weinacker, C.S. Deutschman,

B.A. Kohl, E. Demissie, S. Bellamy, L.B. Ware for the Lung Transplant Outcomes

Group. Plasma Levels of Receptor for Advanced Glycation End Products, Blood

Transfusion, and Risk of Primary Graft Dysfunction. Am J Respir Crit Care Med

2009;180 1010-1015.

WJ Kim, EK Silverman, E Hoffman, GJ Criner, Z Mosenifar, FC Sciurba, BJ Make, V Carey, RS

Estépar, A Diaz, JJ Reilly, FJ Martinez, GR Washko; NETT Research Group. CT metrics

of airway disease and emphysema in severe COPD. Chest 2009;136(2):396-404.

R. Benzo, MH Farrell, CC Chang, FJ Martinez, R Kaplan, J Reilly, G Criner, R Wise, B Make, J

Luketich, AP Fishman, FC Sciurba; NETT Research Group. Integrating health status and

survival data: the palliative effect of lung volume reduction surgery. Am J Respir Crit

Care Med 2009;180:239-46.

MK Han, R Wise, J Mumford, F Sciurba, GJ Criner, JL Curtis, S Murray, A Sternberg, G

Weinman, E Kazerooni, AP Fishman, B Make, EA Hoffman, Z Mosenifar, FJ Martinez;

NETT Research Group. Prevalence and clinical correlates of bronchoreversibility in

severe emphysema. Eur Respir J 2010;35:1048-56.

ND Giardino, JL Curtis, AC Andrei, VS Fan, JO Benditt, M Lyubkin, K Naunheim, G Criner, B

Make, RA Wise, SK Murray, AP Fishman, FC Sciurba, I Liberzon, FJ Martinez; NETT

Research Group. Anxiety is associated with diminished exercise performance and quality

of life in severe emphysema: a cross-sectional study. Respir Res 2010;11:29.

RP Benzo, CC Chang, MH Farrell, R Kaplan, A Ries, FJ Martinez, R Wise, B Make, F Sciurba;

NETT Research Group. Physical activity, health status and risk of hospitalization in

patients with severe chronic obstructive pulmonary disease. Respiration 2010;80:10-8.

D Chandra, DA Lipson, EA Hoffman, J Hansen-Flaschen, FC Sciurba, MM Decamp, JJ Reilly,

GR Washko; National Emphysema Treatment Trial Research Group. Perfusion

scintigraphy and patient selection for lung volume reduction surgery. Am J Respir Crit

Care Med 2010;182:937-46.

M.A. Puhan, D. Chandra, Z. Mosenifar, A. Ries, B. Make, N.N. Hansel, R.A. Wise, F. Sciurba;

National Emphysema Treatment Trial (NETT) Research Group. The minimal important

difference of exercise tests in severe COPD. Eur Respir J 2011;37:784-90.

C.E. Come, M.J. Divo, R. San José Estépar, F.C. Sciurba, G.J. Criner, N. Marchetti, S.M. Scharf,

Z. Mosenifar, B.J. Make, C.A. Keller, O.A. Minai, F.J. Martinez, M.K. Han, J.J. Reilly,

B.R. Celli, G.R. Washko; NETT Research Group. Lung deflation and oxygen pulse in

COPD: results from the NETT randomized trial. Respir Med 2012;106:109-19.

V Kim, DM Kretschman, AL Sternberg, MM DeCamp Jr, GJ Criner; National Emphysema

Treatment Trial Research Group.Weight gain after lung reduction surgery is related to

improved lung function and ventilatory efficiency. Am J Respir Crit Care Med

2012;186(11):1109-16.




















24

R Benzo, W Siemion, P Novotny, A Sternberg, RM Kaplan, A Ries, R Wise, F Martinez, J Utz, F

Sciurba; National Emphysema Treatment Trial Research Group. Factors to inform

clinicians about the end of life in severe chronic obstructive pulmonary disease. J Pain

Symptom Manage 2013;46(4):491-499.

V. Kim, AL Sternberg, G Washko, BJ Make, MK Han, F Martinez, GJ Criner; National

Emphysema Treatment Trial Research Group. Severe chronic bronchitis in advanced

emphysema increases mortality and hospitalizations. COPD 2013;10(6):667-78.

K.C. Meyer, G Raghu, GM Verleden, PA Corris, P Aurora, KC Wilson, J Brozek, AR Glanville;

ISHLT/ATS/ERS BOS Task Force Committee; ISHLT/ATS/ERS BOS Task Force

Committee. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and

management of bronchiolitis obliterans syndrome. Eur Respir J 2014;44(6):1479-503.

E. Cantu, RJ Shah, W Lin, ZJ Daye, JM Diamond, Y Suzuki, JH Ellis, CF Borders, GA Andah, B

Beduhn, NJ Meyer, M Ruschefski, R Aplenc, R Feng, JD Christie; Lung Transplant

Outcomes Group Investigators. Oxidant stress regulatory genetic variation in recipients

and donors contributes to risk of primary graft dysfunction after lung transplantation. J

Thorac Cardiovasc Surg 2015;149(2):596-602.

M. Eberlein, RM Reed, S Bolukbas, JM Diamond, KM Wille, JB Orens, RG Brower, JD Christie;

Lung Transplant Outcomes Group. Lung size mismatch and primary graft dysfunction

after bilateral lung transplantation. J Heart Lung Transplant 2015;34(2):233-40.

A. Kapila, MA Baz, VG Valentine, SM Bhorade; AIRSAC investigators. Reliability of diagnostic

criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey. J Heart

Lung Transplant 2015;34(1):65-74.

D.M. Sayah, B Mallavia, F Liu, G Ortiz-Muñoz, A Caudrillier, A DerHovanessian, DJ Ross, JP

Lynch 3rd, R Saggar, A Ardehali; Lung Transplant Outcomes Group Investigators, LB

Ware, JD Christie, JA Belperio, MR Looney. Neutrophil extracellular traps are

pathogenic in primary graft dysfunction after lung transplantation. Am J Respir Crit Care

Med 2015;191(4):455-63.

R.M. Kotloff, S Blosser, GJ Fulda, D Malinoski, VN Ahya, L Angel, MC Byrnes, MA DeVita,

TE Grissom, SD Halpern, TA Nakagawa, PG Stock, DL Sudan, KE Wood, SJ Anillo, TP

Bleck, EE Eidbo, RA Fowler, AK Glazier, C Gries, R Hasz, D Herr, A Khan, D

Landsberg, DJ Lebovitz, DJ Levine, M Mathur, P Naik, CU Niemann, DR Nunley, KJ

O'Connor, SJ Pelletier, O Rahman, D Ranjan, A Salim, RG Sawyer, T Shafer, D Sonneti,

P Spiro, M Valapour, D Vikraman-Sushama, TP Whelan; Society of Critical Care

Medicine/American College of Chest Physicians/Association of Organ Procurement

Organizations Donor Management Task Force. Management of the Potential Organ

Donor in the ICU: Society of Critical Care Medicine/American College of Chest

Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit

Care Med 2015;43(6):1291-325.

E. Cantu, R.J. Shah, W. Lin, Z.J. Daye, J.M. Diamond, Y. Suzuki, J.H. Ellis, C.F. Borders, G.A.

Andah, B. Beduhn, N.J. Meyer, M. Ruschefski, R. Aplenc, R. Feng, J.D. Christie; Lung

Transplant Outcomes Group Investigators. Oxidant stress regulatory genetic variation in

recipients and donors contributes to risk of primary graft dysfunction after lung

transplantation. J Thorac Cardiovasc Surg 2015;149(2):596-602.






















25

J.W. Dodd, P. Novotny, F.C. Sciurba, R.P. Benzo; NETT Research Group. Executive Function,

Survival, and Hospitalization in Chronic Obstructive Pulmonary Disease. A Longitudinal

Analysis of the National Emphysema Treatment Trial (NETT). Ann Am Thorac Soc

2015;12(10):1473-81.

Case Reports, peer reviewed:

S.M. Arcasoy, M.K. Bajwa, J.R. Jett. Non-Hodgkin's Lymphoma presenting as Pancoast

Syndrome. Respir Med 1997;91:571-3. *

S.M. Arcasoy, J.W. Kreit. Recurrent sinusitis, arthralgias, and progressive dyspnea in a 26-year-

old woman. Chest 1999;115:1731-4. *

D. Kreisel, F.H.C. Engels, A.S. Krupnick, W.Y. Szeto, A.M. Krasinskas, S.H. Popma, J.E.

Tomaszewski, S.M. Arcasoy, R.M. Kotloff, N.P. Blumenthal, J.F. Buell, B.R. Rosengard.

Emergent retransplantation after discovery of two primary malignancies in the donor.

Transplantation 2001;71:1859-62.

D.J. Lederer, S.M. Kawut, J.R. Sonett, E. Vakiani, S.L. Seward, Jr., J.G. White, J.S. Wilt, C.C.

Marboe, W. A. Gahl, S. M. Arcasoy. Successful bilateral lung transplantation for

pulmonary fibrosis associated with the Hermansky-Pudlak Syndrome. J Heart Lung

Transplant 2005;24:1697-9. *

S.M. Kawut, A.M. Assaad, S.M. Arcasoy, E.B. Rosenzweig, J.R. Sonett, A. Borczuk. Pulmonary

capillary hemangiomatosis. Results of gene expression analysis. Chest 2005;128:575S-

6S.

G.N. Herlitz, D.I. Sternberg, R. Palazzo, S. Arcasoy, J.R. Sonett. Treatment of bronchomalacia in

cystic fibrosis by silicone stent. Ann Thorac Surg 2006;82:2268-70.

Reviews, Chapters and Editorials:

S.M. Arcasoy, J.R. Jett. Mediastinoscopy. In: Parsons PE, Heffner JE, eds. Pulmonary/Respiratory

Therapy Secrets. Hanley & Belfus, Inc., Philadelphia, PA, 1997, pp. 81-6. *

S.M. Arcasoy, J.R. Jett. Pancoast’s syndrome and (superior) pulmonary sulcus tumors. In:

Weinberger SE (Ed.) UpToDate in Pulmonology and Critical Care Medicine. Vol 6(1).

UpToDate, Inc., Wellesley, MA, 1998. *

S.M. Arcasoy, J.R. Jett. Pancoast’s syndrome-reply (letter). N Engl J Med 1998;338:765. *

S.M. Arcasoy, D.C. Strollo, M.L. Rosado de Christenson. Disorders of the mediastinum. In: Albert

RK, Spiro SG and Jett JR, eds. Comprehensive Respiratory Medicine. Mosby International,

Harcourt Brace & Company Ltd, London, England, 1999, pp. 74.1-74.10.*

S.M. Kawut, M. Mandel, S.M. Arcasoy. Two faces of progressive dyspnea. Chest 2000;117:1500-

4.*





26

S.M. Kawut, S.M. Arcasoy. Pancoast’s syndrome. In: Heffner JE and Sahn SA, eds. Internal

Medicine Pearls, 2nd Edition, Hanley & Belfus, Inc., Medical Publishers, Philadelphia, PA,

2000, pp 63-5.*

S.M. Arcasoy. Pulmonary embolism. In: David Goldmann, ed. Physicians’ Information and

Education Resource (PIER) Clinical Guidance Modules. American College of Physicians

-American Society of Internal Medicine, Philadelphia, PA, 2001. *

S.M. Arcasoy, G. Tino. Clinical Aspects of Obstructive Lung Disease. Seminars in Roentgenology

2001;36:6-11, 2001. *

S.M. Arcasoy, P. Lanken. Pulmonary alveolar proteinosis. Images in Clinical Medicine. N Engl J

Med 2002;347:2133. *

S.M. Arcasoy. Thrombolysis in venous thromboembolism. Managing Antithrombotic Therapy

from Consensus Statement to Clinical Practice. In ATS 2002 Conference. Symposia

Excerpts. *

S.M. Arcasoy, A. Vachani. Local and systemic thrombolytic therapy for acute venous

thromboembolism. Clinics in Chest Medicine 2003;24:73-91. *

B.N. Medoff, S.M. Arcasoy. Whole lung lavage. In: Beamis JF, Mathur P, Mehta A, eds. Interventional

Pulmonary Medicine. Marcel Dekker, Inc., New York, NY, 2004, pp.329-54. *

S. Arcasoy, S. Kawut. Thrombolytic therapy may have no mortality benefit over intravenous

heparin in acute pulmonary embolism (Commentary). Evidence-based Cardiovasc Med

2003;7:81-2. *

S.M. Arcasoy. Medical complications and management of lung transplant recipients. Respir Care

Clin 2004;10:505-29. *

D.C. Strollo, M.L. Rosado de Christenson, S.M. Arcasoy. Disorders of the mediastinum. In: Albert

RK, Spiro SG and Jett JR, eds. Clinical Respiratory Medicine, 2nd Edition. Mosby,

Philadelphia, PA, 2004, pp. 789-800. *

A. Vachani, S.M. Arcasoy. Thrombolytic therapy for deep venous thrombosis. Analysis of benefits and

risks. Clin Pulm Med 2004;11:328-34.*

S.M. Arcasoy, J. Wilt. Medical complications after lung transplantation. Sem Respir Crit Care

Med 2006;27:508-20. *

S.M. Arcasoy, J.R. Jett, S.E. Schild. Pancoast’s syndrome and (superior) pulmonary sulcus tumors-

I. In: Weinberger SE (Ed.) UpToDate in Pulmonology and Critical Care Medicine. Vol

6(1). UpToDate, Inc., Wellesley, MA, updated and modified in 2006. *

S.M. Arcasoy. Selection of patients with cystic fibrosis for lung transplantation. In: Braunwald E,

Fauci AS, Isselbacher KJ, Kasper DL, Hauser SL, Longo DL, Jameson JL (Eds.)

Harrison’s Online. 2007. *

D.J. Lederer, S.M. Arcasoy. Update in surgical therapy for chronic obstructive pulmonary disease.

Clin Chest Med. 2007;28:639-53. *


27

S.M. Arcasoy. Controversies in bronchogenic carcinoma following lung transplantation: Type of

transplant operation and role of screening. J Thorac Oncology 2008;3:1377

H.Y. Robbins, S.M. Arcasoy. Chapter 11: Recipient Management Pre-Transplant; In W.T.

Vigneswaran, MD and E.R. Garrity (Eds.) Lung Biology in Health and Disease. Lung

Transplantation. 2009;243:99-104. *

S.M. Arcasoy. Current state of lung transplantation: In L.S. Sher, D. Cramer, J.M. Grinyo (Eds.)

Curr Opin in Organ Transplant. 2009;14:463-5. *

H.Y. Robbins, S.M. Arcasoy. Malignancies Following Lung Transplantation. Clin Chest Med

2011;32:343-55.*

H.Y. Robbins, S.M. Arcasoy. Lung Transplant in the COPD Patient. Lung Health Professional

Magazine. 2011;2:6-8

D.J. Lederer, S.M. Arcasoy. Two, one, or none for chronic obstructive pulmonary disease: Who

decides and how? Am J Respir Crit Care Med 2011;184:1226-7.

B. Harris, F.D.Lowy, D.E.Stover, S.M. Arcasoy. Diagnostic bronchoscopy in solid-organ and

hematopoietic stem cell transplantation. Ann Am Thorac Soc 2013;10:39-49.

S.M. Arcasoy, F Cordova. The fall in FVC after lung transplantation. A sentinel event. Am J Respir

Crit Care Med 2015; 192:127-8.

L.J. Benvenuto, M.R. Anderson, S.M. Arcasoy. New frontiers in immunosuppression. J Thorac

Dis 2018;10(5):3141-55.

Abstracts:

S.M. Arcasoy, J.D. Latoche, M. Gondor, R.J. Henderson, R. Hughey, O.J. Finn, J.M. Pilewski.

Sialoglycoconjugates such as MUC1 reduce the efficiency of adenovirus-mediated gene

transfer to epitheliaL cells in vitro and in vivo. Ped Pulmon 1996;13:A206.

X.S. Jiang, M. Gondor, S.M. Arcasoy, J.M. Pilewski, J.R. Yankaskas, O.A. Weisz. Comparison of

glycosylation in CF and control airway epithelial cells. Ped Pulmon 1996;13:A291.

R.P. Tomkiewicz, O.E. Ramirez, T. Dian, C. Kishioka, S. Arcasoy, J. Pilewski, B.K. Rubin.

Physical properties of mucus from cystic fibrosis and non-CF human bronchial xenografts.

Ped Pulmon 1996;13:A154.

S.M. Arcasoy, M. Gondor, J.D. Latoche, R.A. Henderson, R. Hughey, O.J. Finn and J.M. Pilewski.

MUC1 and tight junctions contribute to the inefficiency of adenoviral-mediated gene

transfer to differentiated airway epithelia. Am J Respir Crit Care Med 1996;153:A765.

J.D. Latoche, S.M. Arcasoy, D.C. Devor, J.M. Pilewski. Adenovirus-mediated CFTR gene transfer

corrects oversulfation of secreted glycoconjugates in cystic fibrosis airway epithelial cells.

Ped Pulmon 1997;14:A276.


28

S.M. Arcasoy, S.S. Desai, J.D. Latoche, J.M. Pilewski. MUC1 mucin inhibits adhesion of

Pseudomonas aeruginosa to epithelial cells. Am J Respir Crit Care Med 1998;157:A582.

S.S. Desai, S. M. Arcasoy, J.D. Latoche, S. Watkins, J.M. Pilewski. Bacterial exoproducts and

inflammatory cytokines decrease MUC1 expression in human airway epithelial cells. Am

J Respir Crit Care Med 1998;157:A728.

S.M. Arcasoy, J.D. Edelman, P.M. Wahl, N. Blumenthal, H.I. Palevsky, R.M. Kotloff.

Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation.

Am J Respir Crit Care Med 2000;161:A720.

J.D. Christie, S.M. Arcasoy, S.E. Kimmel, D.A. Zisman, N.P. Blumenthal, H.I. Palevsky, B.L.

Strom, J. Hansen-Flaschen, R.M. Kotloff. Clinical risk factors for development of primary

graft failure following lung transplantation. Am J Respir Crit Care Med 2001;163:A343.

J.D. Christie, S.M. Arcasoy, S.E. Kimmel, D.A. Zisman, N.P. Blumenthal, H.I. Palevsky, B.L.

Strom, J. Hansen-Flaschen, R.M. Kotloff. Impact of primary graft failure on clinical outcomes following lung transplantation. Am J Respir Crit Care Med 2001;163:A343.

D.A. Zisman, J.R. Kizer, N.P. Blumenthal, J. Hansen-Flaschen, S.M. Arcasoy, V.A. Ferrari, R. M.

Kotloff. Non-granulomatous interstitial lung disease is associated with coronary

atherosclerosis. Am J Respir Crit Care Med 2001;163:A713.

S. M. Arcasoy, J.D. Christie, V.A. Ferrari, N.P. Blumenthal, M. St John Sutton, D.A. Zisman, H.

I. Palevsky, R.M. Kotloff. The utility of Doppler Echocardiography for estimation of

pulmonary artery pressures in patients with advanced lung disease. Am J Respir Crit Care

Med 2001;163:A343.

S.M. Arcasoy, C. Hersh, J.D. Christie, N.P. Blumenthal, D.A. Zisman, H.I. Palevsky, R.M. Kotloff.

Bronchogenic Carcinoma after Lung Transplantation. Am J Respir Crit Care Med

2001;163:A338.

J.D. Christie, S.M. Arcasoy, D. Lipson, D. Zisman, N. Blumenthal, K. Pescatore, J. Hansen-

Flaschen, R.M. Kotloff. Donor race and gender are independently associated with the

development primary graft failure following lung transplantation. Chest 2001;120:205S.

S.M. Kawut, M.K. O’Shea, M.N. Bartels, J.R. Sonett, S.M. Arcasoy. Oxygen consumption predicts

outcomes in lung transplant candidates with pulmonary fibrosis. J Heart Lung Transplant

2003;22:S182.*

J.S. Wilt, S.M. Arcasoy, J. Sonett, S. Kawut. Hypogammaglobulinemia following lung

transplantation is associated with severe recurrent infections. Chest 2003;124:258S.

L. Shah, S.M. Kawut, J.S. Wilt, M.K. O'Shea, J.R. Sonett, S.M. Arcasoy.

Hypogammaglobulinemia after lung transplantation. J Heart Lung Transplant 2004;

23:S95.

A. Stewart, S. Arcasoy, S. Kawut, J. Wilt, J.Sonett. Prevention of severe ischemic-reperfusion

injury using a multifaceted approach during procurement, storage and reperfusion in lung

transplantation. J Heart Lung Transplant 2004;23:S152.


29

S.M. Bhorade, V. Ahya, R. Kotloff, M. Baz, V. Valentine, S. Arcasoy, R. Love, R. Young, W.T.

Vigneswaran, E.R. Garrity. Comparison of sirolimus versus azathiprine in a tacrolimus

based immunosuppressive regimen in lung transplantation. J Heart Lung Transplant

2004;23:S113.

L. Shah, S.M. Kawut, J.S. Wilt, E. Dwyer, J.R. Sonett, S.M. Arcasoy. Female predominance of

severe hypogammaglobulinemia after lung transplantation. Am J Respir Crit Care Med

2004;169:A505

A. Reyentovich, S. M. Kawut, J.S. Wilt, R. Anzeck, J.R. Sonett, S.M. Arcasoy. Specific donor

and recipient characteristics and short-term outcomes in lung transplantation. Am J Respir

Crit Care Med 2004;169:A272

A.M. Assaad, S.M. Kawut, S.M. Arcasoy, E.B. Rosenzweig, J.R. Sonett and A.C. Borczuk.

Pulmonary capillary hemangiomatosis: Results of gene expression analysis. Modern Path

2004;17:333A

S.M. Bhorade, V. Ahya, R. Kotloff, M. Baz, V. Valentine, S. Arcasoy, R. Love, W.T.

Wigneswaran, E.R. Garrity. Six-month results of sirolimus versus azathioprine in a

tacrolimus based immunosuppressive regimen in lung transplantation. J Heart Lung

Transplant 2005;24:S153.

D.J. Lederer , M.K. O'Shea, M.N. Bartels, J.S. Wilt, J.R. Sonett, S.M. Arcasoy, S.M. Kawut.

Racial and Ethnic Disparities in Survival among Patients with Diffuse Parenchymal

Lung Disease. Am J Respir Crit Care Med 2005;2:242.

N.H. Yip, D.J. Lederer, S.M. Kawut, J.S. Wilt, J.R. Sonett, S.M. Arcasoy. Immunoglobulin G

(IgG) Levels Before and After Lung Transplantation. Am J Respir Crit Care Med

2005;2:A590.

S.M. Kawut, J. Fleischer, V. Adesso, J.S. Wilt, M.K. O’Shea, J.R. Sonett, E. Shane, S.M.

Arcasoy. Bone mineral density in diffuse parenchymal lung disease. Am J Respir Crit

Care Med 2005;2:A126.

Y.M. Odeh, S.M. Kawut, J.S. Wilt, A.C. Borczuk, E.M. Horn, E.B. Rosenzweig, D.I. Sternberg,

S.M. Arcasoy, J.R. Sonett. Outcomes after lung biopsy in severe pulmonary hypertension

compared to interstitial lung disease. Am J Respir Crit Care Med 2005;2:A203.

B. Lu, E. Garrity, V. Ahya, R. Kotloff, M. Baz, V. Valentine, S. Arcasoy, R. Love, S. Bhorade.

Utility of surveillance bronchoscopy after lung transplantation. Am J Respir Crit Care

Med 2005;2:A892.

C.E. Caplan-Shaw, S.M. Kawut, J.R. Sonett, G.D. Pearson, A. Rozenshtein, M.A. Apfelbaum,

S.M. Arcasoy, J.S. Wilt. Left main coronary artery compression by an enlarged

pulmonary artery in pulmonary hypertension due to diffuse parenchymal lung disease and

successful treatment by lung transplantation. Chest 2005;128:435S.

D.J. Lederer, S.M. Arcasoy, J.S. Wilt, H.A. Yegen, F. D'Ovidio, J.R. Sonett, S.M. Kawut. Six

Minute Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis. J

Heart Lung Transplant 2006;25:S61-2.


30

S.M. Bhorade, V. Ahya, R. Kotloff, M. Baz, V. Valentine, S. Arcasoy, R. Love, R. Durazo, W.T.

Vigneswaran, E.R. Garrity. Incidence of renal failure in lung transplant recipients

receiving tacrolimus and sirolimus immunosuppressive regimen. J Heart Lung


S. Keshavjee, E.P. Trulock, R.L. Doyle, R.D. Davis, J.G. Golden, K.R. McCurry, J.S. Wilt, M.

Strueber, S.M. Arcasoy, G.H. Caughey, S. Sweet, P. Jaksch, P.A. Corris, A.C. Mehta,

M.S. Mulligan, O.E. Pajaro, R. Woodward, T.M. Klingler, J.G. Wohlgemuth, S.

Rosenberg, P. Lal, J. Phillips, K.C. Fang, M.R. Zamora. Immunoregulatory influences on

peripheral blood gene expression in lung transplant patients: The lung allograft gene

expression observational (LARGO) study. J Heart Lung Transplant 2006;25:S78.

D. Sternberg, R. Gowda, J. Sarkar, S. Arcasoy, J.M. D’Armiento, A.M. Schmidt, J.R. Sonett.

Interruption of the receptor for advanced glycation end product pathway attenuates

pulmonary reperfusion injury. J Heart Lung Transplant 2006;25:S90.

D.J. Lederer, S.M. Arcasoy, R.G. Barr, J.S.Wilt, F. D'Ovidio, E. Bagiella, J.R. Sonett, S.M

Kawut. Disparities in Survival in Minority Patients with Idiopathic Pulmonary Fibrosis.

Am J Respir Crit Care Med 2006;3:A523.

H.A. Yegen, D.J. Lederer, J.S. Wilt, R.G. Barr, F. D'Ovidio, S.M. Arcasoy, J.R.. Sonett, S.M.

Kawut. Risk Factors for Venous Thromboembolism (VTE) in Lung Transplant

Recipients. Am J Respir Crit Care Med 2006;3:A536.

D.I Sternberg, G. Herlitz, J. Sarkar, S. Kawut, D. Shimbo, J. Wilt, S. Arcasoy, J. D’Armiento,

J.Sonett. Post-operative platelet activation following lung transplantation. Am J Respir

Crit Care Med 2006;3:A365.

S. Keshavjee, K.R. McCurry, R.D. Davis, J.M. Pilewski, P.A. Corris, A. Zeevi, T.K. Waddell,

S.M. Arcasoy, J.G. Golden, M. Strueber, R.L. Doyle, P. Jaksch, A.C. Mehta, M.S.

Mulligan, O.E. Pajaro, M.R. Zamora, S. Sweet, R.N. Woodward, R.D. Dedrick, H.

Wolters, K.C. Fang, E.P. Trulock. Effect of induction therapy on the peripheral blood

genomic signature in the LARGO lung transplant study. J Heart Lung Transplant

2007;26:S212.

S. Keshavjee, G. Berry, C.C. Marboe, J.S. Wilt, E.P. Trulock, P.A. Corris, R.L. Doyle, K.R.

McCurry, S.M. Arcasoy, R.D. Davis, J.G. Golden, M. Strueber, S. Sweet, P. Jaksch, A.C.

Mehta, M.S. Mulligan, O.E. Pajaro, J.T. Sun, T.M. Klingler, S. Rosenberg, R.D. Dedrick,

H. Wolters, K.C. Fang, M.R. Zamora. Refining the identification of discriminatory genes

for rejection in lung transplantation: The LARGO Study. J Heart Lung Transplant

2007;26:S185.

S.M. Kawut, D.J. Lederer, J.S. Wilt, F.D. D’Ovidio, J.R. Sonett, S.M. Arcasoy, S. Keshavjee,

M.L. Barr. A UNOS Registry analysis of lung retransplantation in the modern era. J

Heart Lung Transplant 2007;26:S206.

N. Al-Naamani, O. Maarouf, D. Rybak, J.S. Wilt, F. D'Ovidio, J.R. Sonett, S.M. Arcasoy, D.J.

Lederer, T.L. Nickolas, S.M. Kawut. Assessing Renal Function in Lung Transplant

Candidates. Am J Respir Crit Care Med 2007;175:A376.


31

E.K. Benn, S.M. Arcasoy, J.S. Wilt, F. D'Ovidio, J.R. Sonett, S.M. Kawut, D.J. Lederer. Blacks

with COPD Have More Medical Comorbidities than Whites at Listing for Lung

Transplantation. Am J Respir Crit Care Med 2007;175:A846.

M.D. Bachetta, A. Biviano, F.A. Ehlert, H. Garan, J. Dizon, W. Whang, J. Cormilas, K. Hickey,

J. Wilt, F. D’Ovidio, S. Arcasoy, J.R. Sonett. Postoperative arrhythmias in lung

transplantation. J Heart Lung Transplant 2008;27:S81

N. Al-Naamani, O.H. Maarouf, J.S. Wilt, F. D’Ovidio, J.R. Sonett, S. M. Arcasoy, T.L. Nickolas,

D.J. Lederer, S.M. Kawut. The modification of diet in renal disease (MDRD) formula

predicts kidney failure after lung transplantation. J Heart Lung Transplant 2008;27:S69.

N. Al-Naamani, O.H. Maarouf, V.N. Ahya, D.J. Lederer, J.D. Mendez, J.S. Wilt, D. Rybak, M.

Tufariello, F. D’Ovidio, J.R. Sonett, S. M. Arcasoy, T.L. Nickolas, S.M. Kawut.

Validation of the modification of diet in renal disease (MDRD) in estimating GFR in lung

transplant candidates. J Heart Lung Transplant 2008;27:S80

R.F. Tavares de Melo, T.S. Lukose, S. Bae, C.J. Kubin, D.J. Lederer, S.M. Arcasoy, J.S. Wilt,

J.R. Sonett, F. D’Ovidio, S.M. Kawut. The effect of CMV-Immune globulin on outcomes

in CMV-mismatched lung transplant recipients. J Heart Lung Transplant 2008;27:S79

S.M. Bhorade, M. Baz, V. Ahya, H. Seethamraju, V. Valentine, S. Arcasoy, R. Love, C. Alex,

W.T. Vigneswaran, J.A. Krishnan, J. Charbeneau, E.R. Garrity. Comparison of a

Tacrolimus/Sirolimus/Prednisone regimen versus Tacrolimus/Azathiprine/Prednisone

immunosuppressive regimen in lung transplantation. J Heart Lung Transplant

2008;27:S207.

M.J. Russo, D. Sternberg, K.N. Hong, A.J. Moskowitz, A.C. Gelijns, D.J. Lederer, J. Wilt, F.

D’Ovidio, S.M. Kawut, S.M. Arcasoy, J.R. Sonett. Despite decreasing wait times for lung

transplantation, lung allocation score continues to increase. J Heart Lung Transplant

2008;27:S252

S.M. Arcasoy, C. Marboe, S. Keshavjee, on behalf of LARGO Investigators. Variability in the

pathologic interpretation of transbronchial lung biopsy after lung transplantation. Clinical

Implications. J Heart Lung Transplant 2008;27:S131.

D.C. Abrams, D.J. Lederer, S.M. Kawut, J.S. Wilt, F. D’Ovidio, J.R. Sonett, C.C. Marboe, S.M.

Arcasoy. Histological . Alveolar Injury Pattern Predicts Survival after Lung

Transplantation. Am J Respir Crit Care Med 2008;177:A308.

D.J. Lederer, S.M. Kawut, J.S. Wilt, F. DOvidio, J.R. Sonett, S.M. Arcasoy. A Modified BODE

Index Predicts Waiting List Survival in COPD. Am J Respir Crit Care Med 2008;177:

A397.

D.J. Lederer, E.K. Benn, R.G. Barr, J.S. Wilt, G. Reilly, J.R. Sonett, S.M. Arcasoy, S.M.

Kawut.Racial Differences in Waiting List Outcomes in Chronic Obstructive Pulmonary

Disease. Am J Respir Crit Care Med 2008;177:A397.

R.J. Shah, D.J. Lederer, S.M. Kawut, L.B. Ware, J.D. Christie, S.M. Arcasoy.Early Lung

Transplant Outcomes in the New Allocation System: A Multicenter Study. Am J Respir


32

Crit Care Med 2008;177:A397.

S.M. Bhorade, M. Baz, M.D., V. Ahya, H. Seethamraju, V. Valentine, S. Arcasoy, R. Love, N.

De Oliveira, C. Alex, W.T. Vigneswaran, J.A. Krishnan, J. Charbeneau, E.R. Garrity.

Comparison of Infection Rates between Sirolimus and Azathioprine in a Tacrolimus

Based Immunosuppressive Regimen after Lung Transplantation. Am J Respir Crit Care

Med 2008;177:A394.

S. Park, S.M. Kawut, P.F. Simonelli, N.M. Patel, N. Al-Naamani, D. Rybak, N.W. Schluger,

S.M. Arcasoy, D.J. Lederer. Socioeconomic Status and Disease Severity in Diffuse

Parenchymal Lung Disease. Am J Respir Crit Care Med 2008;177:A250.

S.M. Bhorade, V. Ahya, R. Kotloff, M. Baz, V. Valentine, S. Arcasoy, R. Love, A. de Oliveira,

R. Bag, H. Seethamraju, C. Alex, W.T. Wigneswaran, J. Charbeneau, J. Krishnan, R.

Durazo, E.R. Garrity. Long-term Follow-up in the AIRSAC Trial, a Multicenter

Randomized Clinical Trial in Lung Transplant Recipients. J Heart Lung Transplant

2009;28:S119

P.J. McShane, S.M. Bhorade, M. Baz, V. Valentine, S. Arcasoy, R. Love, H. Seethamraju, E.

Garrity, C. Alex, R. Bag, A. de Oliveira, W. Wigneswaran, J. Charbeneau, J. Krishnan,

R. Durazo, V. Ahya. Sirolimus is Associated with an Increased Risk of Venous

Thromboembolism in Lung Transplantation. J Heart Lung Transplant 2009;28:S139.

M.J. Russo, A. Iribarne, R.R. Davies, K.N. Hong, S. Xydas, A.C. Gelijns, M.D. Bacchetta, F.

D’Ovidio, S. Arcasoy, J.R. Sonett. Elevated Lung Allocation Score is Associated with

Decreased Survival and Increased Complications after Lung Transplantation. J Heart

Lung Transplant 2009;28:S167.

S. McClelland, S.-W. Pak, S. Kawut, J. Parks, D. Spiliotopoulos, T. Scripps, J. Gerson, F.

D’Ovidio, M. Bacchetta, S. Arcasoy, J. Sonett. Lung Donor Scoring Can Optimize Donor

Management, Refine Organ Utilization, and Predict Recipient Outcomes. J Heart Lung


M. Latreille, D. Zemmel, N. Philip, D. Rybak, J. Wilt, N. Patel, S.M. Kawut, S.M. Arcasoy, D.J.

Lederer. Criterion Validity of the Duke Activity Status Index in Diffuse Parenchymal

Lung Disease. Am J Respir Crit Care Med 2009;179:A2983

S.M. Bhorade, V. Valentine, V. Ahya, M. Baz, S. Arcasoy. Interobserver Variability of Acute

Cellular Lung Rejection: A Review of 310 Surveillance Biopsies from the AIRSAC

Trial. Am J Respir Crit Care Med 2009;179:A2542

D.J. Lederer, J. Wilt, F. D'Ovidio, M. Bacchetta, J.R. Sonett, S.M. Arcasoy. Pretransplant Body

Mass Index Is Associated with Late Mortality after Lung Transplantation. Am J Respir

Crit Care Med 179;2009:A2548

J.S. Wilt, S.M. Arcasoy, F.D. D’Ovidio, M.D. Bacchetta, L. Whitley, L. Shah, J.R. Sonett, D.J.

Lederer. A clinical prediction rule for selection of mechanically ventilated lung transplant

candidates. J Heart Lung Transplant 2010;29:S31


33

H. Poor , S.M. Arcasoy, S.M. Kawut, MS2, N. Philip, D. Rybak, M. Huang, N. Patel, L. Shah, J.

Wilt, D.J. Lederer. Elevated Plasma TGF-β1 Levels are Associated with Poor Outcomes

in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 181;2010:A1108.

C. Winterbottom, S.M. Arcasoy, N. Philip, D. Rybak, D. Shimbo, N. Patel, L. Shah, J. Wilt, D.J.

Lederer. Serum CA 15-3, a MUC1 Tumor Marker, is Elevated in Idiopathic Pulmonary

Fibrosis. Am J Respir Crit Care Med 181;2010:A1114.

A. Giunta, S.M. Arcasoy, N. Patel, J. Wilt, D.J. Lederer. Low Socioeconomic Status is associated

with Greater Disease Severity in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care

Med 181;2010:A1123.

J.M. Diamond, V.N. Ahya, S.M. Kawut, D.J. Lederer, S.M. Palmer, M. Crespo, K.M. Wille, V.N.

Lama, P.D. Shah, J.B. Orens, S. Bhorade, A. Weinacker, B. Kohl, C.S. Deutschman, J.

Sonett, D. Weill, S.M. Arcasoy, A. Shah, S. Bellamy, E. Demissie, J.D. Christie, L.B.

Ware. Elevated Plasma Clara Cell Secretory Protein Concentration is Associated with

High-Grade Primary Graft Dysfunction. Am J Respir Crit Care Med 181;2010:A1003.

C. Winterbottom, S.M. Kawut, L.B. Ware, S. Bhorade, S.M. Palmer, K.M. Wille, A. Weinacker,

V.N. Lama, M. Crespo, J.B. Orens, S.M. Arcasoy, J.D. Christie, D.J. Lederer. Obesity is

Associated with an Increased Risk of Primary Graft Dysfunction after Lung

Transplantation: the LTOG Obesity Study. Am J Respir Crit Care Med 181;2010:A1004.

J. Hook, D. Zemmel, N. Philip, D. Rybak, M. Koeckert, L. Shah, M. Bartels, N. Patel, S.M.

Arcasoy, D.J. Lederer. A Novel Point-of-Care Oxygen Titration Study to Predict

Outcome in Interstitial Lung Disease. Am J Respir Crit Care Med 181;2010:A2969.

H. Kim, M. Goldklang, D.J. Lederer, S.M. Arcasoy, J. Cunningham, K.M. Burkart, D. Brodie, J.

Sonett, A. Ibrahimiye, M. Bacchetta. Extubation of Patient With Respiratory Failure

While On Extracorporeal Membrane Oxygenation Support. Am J Respir Crit Care Med

181;2010:A5367.

J.M. Diamond, R. Feng, N. Meyer, D. Lederer, J.Lee, S. Kawut, V. Ahya, E. Cantu, S. Palmer, A.

Weinacker, S. Bhorade, V. Lama, J. Orens, J. Sonett, K. Wille, M. Crespo, D. Weill, B.

Kohl, C. Deutschman, S. Arcasoy, A. Shah, P.D. Shah, E.J, Demissie, J. Reynolds, J.

Belperio, D. Wilkes, L.Ware, J.D. Christie. PTX3 Polymorphisms Are Associated with

Primary Graft Dysfunction after Lung Transplantation. J Heart Lung Transplant 2011;

30:S23.

J.M. Diamond, D. Lederer, S.M. Kawut, J. Lee, E. Cantu, V. Ahya, S. Palmer, A. Weinacker, S.

Bhorade, V.Lama, J.B. Orens, J. Sonett, K. Wille, M. Crespo, D. Weill, B. Kohl, C.

Deutschman, S. Arcasoy, A. Shah, P.D. Shah, E.J. Demissie, J.M. Reynolds, J. Belperio,

D. Wilkes, L. Ware, J.D. Christie. Elevated PTX3 Concentration Is Associated with

Primary Graft Dysfunction after Lung Transplantation in Patients with Idiopathic

Pulmonary Fibrosis. J Heart Lung Transplant 2011; 30: S23.

B. Aramini, S. Diangelo, D. Lederer, J. Wilt, L. Shah, S. Matioli, S. Keshavjee, J. Floros, S.

Arcasoy, J. Sonett, f. D’Ovidio. Donor Lung Surfactant Protein D Gene Polymorphisms

are Associated with Bronchiolitis Oblietrans Syndrome and Mortality after Lung

Transplantation. J Heart Lung Transplant 2011; 30:S56.


34

B. Aramini, P.M. Geraghty, D. Lederer, J. Wilt, L. Shah, S. Mattioli, J. Floros, S. Arcasoy, J.R.

Sonett, F. D’Ovidio. Lung Transplant Immunosuppressive Drugs Influence Pulmonary

Surfactant Protein A (SP-A) Expression. J Heart Lung Transplant 2011; 30:S141.

A. Sireci, T. Thomas, B. Aramini, S. Azad, J. Wilt, M.A. Pesce, S. Arcasoy, J. Sonett, S.

Cremers, F. D’Ovidio. An LC-MS Method for Quantifying Bile Acid Species in

Bronchial Washings of Lung Transplant Patients. J Heart Lung Transplant 2011; 30:

S205.

H.Y. Robbins, S.M. Arcasoy, S. Bhorade, M.M. Crespo, S.M. Kawut, V.N. Lama, J.B. Orens,

S.M. Palmer, P.D. Shah, R. Shah, J.R. Sonett, L.B. Ware, A. Weinacker, K.M. Wille,

J.D.Christie, D.J. Lederer. Temporal Trends in the Prevalence of Primary Graft

Dysfunction After Lung Transplantation Outcomes Group (LTOG) Cohort. J Heart Lung

Transplant 2011; 30: S22.

D.J. Lederer, S.M. Kawut, N. Wickersham, C. Winterbottom, J. Diamond, S. Bhorade, S. Palmer,

J. Lee, K.M. wille, A. Weinacker, V. Lama, M. Crespo, J. Orens, S.M. Arcasoy, L. Ware,

J.D. Christie. Higher Plasma Leptin Levels are Associated with Primary Graft

Dysfunction After Lung Transplantation: The LTOG Obesity Study. J Heart Lung

Transplant 2011; 30: S23.

B.J Ghassemieh, J. Charbeneau, V.N. Ahya, M.A. Baz, V.G. Valentine, S.M. Arcasoy, R.B.

Love, H. Seethamraju, C.G. Alex, R. Bag, N.C. DeOliveira, A. Husain, W.T.

Vigneswaran, J.A. Krishnan, R. Durazo- Arvizu, L. Norwick, E. Garrity, S. Bhorade.

Decreased CMV Infection with Sirolimus Compared to Azathioprine after Lung

Transplantation. J Heart Lung Transplant 2011; 30: S181.

J. Hook, S.M. Arcasoy, D. Zemmel, M. Bartels, S.M. Kawut, D.J. Lederer. Gas Exchange and

Outcome Prediction in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med

2011;183:A1516.

D.J. Lamas, S.M. Kawut, N. Philip, S.M. Arcasoy, D.J. Lederer. Delayed referral to a tertiary

care center is associated with higher mortality in idiopathic pulmonary fibrosis. Am J

Respir Crit Care Med 2011;183:A5298.

H.Y. Robbins, D.J. Lederer, J. Wilt, L. Shah, S.M. Arcasoy. Predicting lung function following

bilateral lung transplantation. Am J Respir Crit Care Med 2011;183:A4657

J.M. Diamond, R. Feng, N.J. Meyer, S.M. Kawut, J.C. Lee, V. Ahya, E. Cantu, L. Ware, S.M.

Palmer, S. Bhorade, V. Lama, A. Weinacker, J. B. Orens, J.Sonett, K.M. Wille, M.

Crespo, D. Weill, B. Kohl, C. Deutschman, S.M. Arcasoy, A. Shah, P. Shah, E.J.

Demissie, J. Reynolds, J.A. Belperio, D. Lederer, J.D. Christie. Genetic Variation In

Prostaglandin E2 Family Members Is Associated With The Development Of Primary

Graft Dysfunction After Lung Transplantation. Am J Respir Crit Care Med

2011;183:A4014.

J. Javidfar, D. Brodie, J. Miller, D.J. Lederer, S.M. Arcasoy, J. Sonett, and M.D. Bacchetta.

Extracorporeal Membrane Oxygenation As A Bridge To Lung Transplantation And

Recovery. Am J Respir Crit Care Med 2011; 183: A3887.


35

R.J. Shah, J.M. Diamond, V.Ahya, S.M. Arcasoy, J.A. Belperio, S. Bhorade, E. Cantu, M.

Crespo, C. Deutschman, E.J. Demissie, S.M. Kawut, B. Kohl, V. Lama, D.J. Lederer,

J.C. Lee, J.B. Orens, S.M. Palmer, J. Reynolds, A. Shah, P. Shah, J.Sonett, K.M. Wille,

A. Weinacker, D.S. Wilkes, L.B. Ware, D. Weill, J.D. Christie. Elevated Monocyte

Chemotactic Protein-1 (MCP-1) Is Associated With Primary Graft Dysfunction

Following Lung Transplantation. Am J Respir Crit Care Med 2011; 183: A4023

Lectures by Invitation:

May 1997 Clinical Workshop: Master Clinicians’ Session, American Thoracic Society International

Conference, San Francisco, CA

Aug. 1997 “Barriers to Gene Therapy of Cystic Fibrosis”-Thoracic Research Conference, Mayo

Clinic, Rochester, MN

Sept. 2000 “Diffuse Parenchymal Lung Diseases”- Management Conference for medical housestaff,

Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, PA

Sept. 2000 “Clinicopathologic Conference-A patient with hemoptysis and right upper lobe

atelectasis”, Department of Medicine, University of Pennsylvania Medical Center,

Philadelphia, PA

Oct. 2000 “A Case of Pulmonary Alveolar Proteinosis”-Housestaff Morning Report, Department of

Medicine, University of Pennsylvania Medical Center, Philadelphia, PA

July 2000 “ASD and Pulmonary Hypertension”-Discussant, Cardiovascular Medicine and

Cardiothoracic Surgery Grand Rounds, University of Pennsylvania School of Medicine,

Philadelphia, PA

Dec. 2000 “Treatment of Massive Pulmonary Embolism: The Role of Thrombolytic Therapy” –

Surgical Grand-Rounds, Department of Surgery, University of Pennsylvania School of

Medicine, Philadelphia, PA

Apr. 2001 “Sensational Successes and Fantastic Failures of Lung Transplantation”, Co-moderator and

Speaker, Sunrise Symposium 5, International Society for Heart & Lung Transplantation,

21st Annual Meeting, Vancouver, Canada

May 2001 “Managing Co-morbidities of Advanced Lung Disease: Osteoporosis, Malnutrition and

Coronary Artery Disease”, Post-graduate Course on Advanced Lung Disease, American

Thoracic Society 97th International Conference, San Francisco, CA

June 2001 “Medical Co-morbidities of Advanced Lung Disease: As Important As Primary Disease”,

Special Lecture, Pulmonary and Critical Care Division, College of Physicians and

Surgeons, Columbia University Hospital, New York, NY

July 2001 “Non-pulmonary Impact of Advanced Lung Disease”, Pulmonary Grand Rounds,

Pulmonary, Allergy and Critical Care Division, University of Pittsburgh Medical Center,

Pittsburgh, PA


36

Oct 2001 “The Role of Thrombolytic Therapy in the Treatment of Massive Pulmonary Embolism”,

Medical Grand Rounds, Graduate Hospital, MCP-Hahnemann University School of

Medicine, Philadelphia, PA

May 2002 “Management of Post-transplant Complications For The Non-transplant Pulmonologist”,

Clinical Topics in Pulmonary Medicine Symposium on Current Problems in Lung

Transplantation, American Thoracic Society 98th International Conference, Atlanta, GA

May 2002 “Thrombolysis in Venous Thromboembolism”, Evening Postgraduate Seminar on

Managing Antithrombotic Therapy: From Consensus Statement to Clinical Practice,

American Thoracic Society 98th International Conference, Atlanta, GA

May 2002 “Management of Life-Threatening Pulmonary Embolism”, Sunrise Seminar, American

Thoracic Society 98th International Conference, Atlanta, GA

June 2002 “Lung Transplantation: Update 2002”, Grand Rounds, Pediatric Pulmonology, Columbia

University College of Physicians and Surgeons, Babies Hospital, New York, NY

Sept 2002 “Overview of Lung Transplantation. Indications, Patient Selection, Complications,

Outcomes and More”, Grand Rounds, Department of Anesthesiology, Columbia

University College of Physicians and Surgeons, New York, NY

Sept 2002 “Indications for Lung Transplantation and Evaluation of the Patient with Pulmonary

Failure”, Transplant in Clinical Practice. An accredited course for the transplant

professional. Sponsered by American Board of Transplant Coordinators and Columbia

University College of Physicians and Surgeons

Oct 2002 “Management of Massive Pulmonary Embolism. The Role of Thrombolytic Therapy”,

Medical Housestaff Lecture, Columbia University College of Physicians and Surgeons,

New York, NY

Nov 2002 “Lung Transplantation. A Rough Road to Breathing Easier”, Medical Grand Rounds,

Columbia University College of Physicians and Surgeons, New York, NY

Dec 2002 “Lung Transplantation. For Whom and When”, Advances in Pulmonary Medicine. Classic

Problems 21st Century Solutions, 4th Annual Conference, Columbia University College of

Physicians and Surgeons, New York, NY

Jan 2003 “2003 Update on Lung Transplantation”, Medical Grand Rounds, Lenox Hill Hospital,

New York, NY

Jan 2003 “Lung Transplantation. A Difficult Journey”, Pulmonary and Critical Care Grand Rounds,

Beth Israel Medical Center, University Hospital and Manhattan Campus for the Albert

Einstein College of Medicine, New York, NY

Jan 2003 “Overview of Lung Transplantation: Medical and Surgical Issues”, CME Course in End-

Stage Lung Disease: Medical and Surgical Management, Columbia University College of

Physicians and Surgeons, Dept of Surgery, Garden City, NY

Jan 2003 “Lung Transplantation Update”, Medical Grand Rounds, Long Island College Hospital,

Brooklyn, NY


37

Feb 2003 “Lung Transplantation. 2003 State-of-the-Art”, Medical Grand Rounds, St. Vincent’s

Medical Center, Bridgeport, CT

Feb 2003 “Overview of Lung Transplantation”, Pulmonary Grand Rounds, Memorial Sloan

Kettering Cancer Center, New York, NY

Mar 2003 “Update on Lung Transplantation”, Pulmonary Grand Rounds, Montefiore Medical Center,

University Hospital for the Albert Einstein College of Medicine, New York, NY

Mar 2003 “Management of Life-threatening Pulmonary Embolism”, Medical Grand Rounds, St.

Vincent’s Medical Center, Bridgeport, CT

Mar 2003 “Approach to a Patient with Interstitial Lung Disease”, Medical Staff Conference, St.


Mar 2003 “Lung Transplantation”, Cardiothoracic Surgery Grand Rounds, Lenox Hill Hospital, New

York, NY

Apr 2003 “Management of Interstitial Lung Disease”, Medical Housestaff Lecture, Columbia


Apr 2003 “Medical and Surgical Management of End-stage Lung Disease”, CME course in New

Jersey, Columbia University College of Physicians and Surgeons, New York, NY

May 2003 “Selection of Candidates for Lung Transplantation”, Sunrise Seminar, American Thoracic

Society 2003, 99th International Conference, Seattle, WA

May 2003 “What Should We Do With This One? Interesting Cases and Their Management”,

Symposium on Advanced Lung Disease in 2003. Lung Transplantation and More,

American Thoracic Society 2003, 99th International Conference, Seattle, WA

Aug 2003 “Overview of Lung Transplantation”, Plenary Session, 17th Asia Pacific Congress on

Diseases of the Chest, Istanbul, Turkey, sponsored by the American College of Chest

Physicians and Turkish Society for Respiratory Investigations

Aug 2003 “Thrombolytic therapy of pulmonary embolism”, Panel Discussion, 17th Asia Pacific

Congress on Diseases of the Chest, Istanbul, Turkey, sponsored by the American College

of Chest Physicians and Turkish Society for Respiratory Investigations

Oct 2003 “Medical Issues in Lung Transplantation”, CME course in New Jersey, Columbia


Oct 2003 “All a Nontransplant Pulmonologist Needs to Know About Lung Transplantation”, Meet-

the-Professor Session, American College of Chest Physicians CHEST 2003, Orlando, FL

Oct 2003 “Natural History and Prognosis of Cystic Fibrosis”, Moderator and Faculty, Panel

Discussion on Advanced Lung Disease and Lung Transplantation, American College of

Chest Physicians 2003, Orlando, FL


38

Nov 2003 “Cystic Fibrosis: Pre, Post and Long-term”, Advances in Lung Transplantation, Transplant

in Clinical Practice, An Accredited CME Course For the Transplant Practitioner,

NewYork-Presbyterian Hospital at Columbia University, New York, NY

Nov 2003 “Lung Transplantation: A Difficult Journey”, Medical Grand Rounds, Hackensack

University Medical Center, Hackensack, NJ

Nov 2003 “Lung Transplantation. A Second Chance”, Medical Grand Rounds, St Luke’s Roosevelt

Medical Center, New York, NY

Dec 2003 “Review of Lung Transplantation”, Physical Therapy Grand Rounds, New York

Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New

York, NY

Dec 2003 “Lung Transplantation. When All Else Fails”, Pulmonary Grand Rounds, NYU Medical

Center, New York, NY

Dec 2003 “Update on Lung Transplantation. For Whom and When”, CME Course on Advances in

Pulmonary Medicine. Classic Problems 21st Century Solutions. 5th Annual Conference,


Jan 2004 “Lung Transplantation”, Pulmonary Grand Rounds, Norwalk Hospital, Affiliate of Yale

University, Norwalk, CT

Jan 2004 “Lung Transplantation. A Second Chance”, Medical Grand Rounds, Mineola, NY

Jan 2004 “Lung Transplantation For the Critical Care Physician”, Critical Care Medicine Grand

Rounds, New York-Presbyterian Hospital, New York, NY

Feb 2004 “Lung Transplantation. A Field Without Borders”, Pulmonary Grand Rounds, S.U.N.Y.

Health Sciences Center, Brooklyn, NY

Apr 2004 “Lung Transplantation. State-of-the-Art in 2004”, Pulmonary Grand Rounds, Cornell

University, Pulmonary and Critical Care Division, New York, NY

Apr 2004 “A Young Woman with Progressive Dyspnea”, Discussant in Clinicopathologic

Conference, Department of Medicine, New York-Presbyterian Hospital, Columbia


Apr 2004 “Primary Lung Graft Failure. Predictors of Outcome”, Satellite Symposium 7, 24th Annual

Meeting and Scientific Sessions of the International Society of Heart and Lung

Transplantation, San Francisco, CA

May 2004 “Medical Issues in Lung Transplantation”, Medical and Surgical Management of End

Stage Lung Disease, CME Course, Columbia University College of Physicians and

Surgeons, Rye, NY

May 2004 “Lung Transplantation in Patients with Medical Co-morbidities”, Symposium D73: Lung

Transplantation: Controversies in Recipient Selection, ATS 2004, 100th International

Conference, Orlando, FL


39

June 2004 “Lung Transplantation 2004 Update: Medical Issues”, Medical and Surgical Management

of End Stage Lung Disease, CME Course, Columbia University College of Physicians and

Surgeons, Bronx, NY

Sept 2004 “Diagnosis of Chronic Lung Allograft Rejection”, Advances in Transplantation, CME

conference by Contemporary Forums, Jersey City, NJ

Oct 2004 “Lung Transplantation For the Community Pulmonologist”, Medical Grand Rounds, St


Nov 2004 “Management of Massive Pulmonary Embolism. When Should Thrombolytic Therapy Be

Used?”, Medical Grand Rounds, St Vincent’s Medical Center, Bridgeport, CT

Dec 2004 “Update on Lung Transplantation. For Whom and When”, CME Course on Advances in

Pulmonary and Critical Care Medicine. Classic Problems 21st Century Solutions. 6th

Annual Conference, Columbia University College of Physicians and Surgeons, New York,

NY

Dec 2004 “Lung Transplantation in 2004. An Update for Critical Care Physicians”, Critical Care

Grand Rounds, NewYork Presbyterian Hospital, Columbia University College of


Jan 2005 “Lung Transplantation. New Lungs, New Challenges”, Pulmonary Grand Rounds, North

Shore University Hospital, Long Island, NY

Jan 2005 “Approach to Diffuse Parenchymal Lung Disease”, Medical Grand Rounds, St Vincent’s


Jan 2005 “Medical Aspects of Lung Transplantation”, Lung Transplantation: Update 2005, CME

Program sponsored by Columbia University College of Physicians and Surgeons,

NewYork-Presbyterian Hospital, Greenwich, CT

Feb 2005 “Medical Aspects of Lung Transplantation”, Lung Transplantation: Update 2005, CME

Program sponsored by Columbia University College of Physicians and Surgeons,

NewYork-Presbyterian Hospital, New York, NY

Mar 2005 “Identifying Organ-Specific Patient Care Issues in Health Maintenance: Lung

Transplantation”, Summit on Enhancing Wellness: Lifelong Success for the Transplant

Patient, American Society of Transplantation, Banff, Alberta, Canada

Mar 2005 “Lung Transplantation. A Guide For the Referring Physician”, Pulmonary Grand Rounds,

Lenox Hill Hospital, New York, NY

May 2005 “Evidence-based practice to optimize lung transplant survival”, C80-Lung

Transplantation: Humors, Regulation, Tolerance, and Survival, Scientific Symposium,

ATS 2005 San Diego-International Conference

May 2005 “Lung Transplantation”, B01-Clinical Year in Review 2, ATS 2005 San Diego-

International Conference


40

June 2005 “From Preventive Medicine to Advanced Treatment of Pulmonary Disease”, Symposium

on Promotion of Heart and Lung Health, sponsored by the NewYork Presbyterian Hospital,

Istanbul, Turkey

July 2005 “Life-threatening Pulmonary Embolism. Management Strategies?”, Medical Grand

Rounds, St Vincent’s Medical Center, Bridgeport, CT

Nov 2005 “The New Lung Transplant Organ Allocation Policy: Will My Patient Ever Get a

Transplant and When Should I Make the Referral?” Meet-the-Professor Session, American

College of Chest Physicians, CHEST 2005, Montreal, Canada

Nov 2005 “Bronchiolitis Obliterans Syndrome”, Panel Discussion, ABCDs of Lung Transplantation

for the Community Pulmonologist, American College of Chest Physicians, CHEST 2005,

Montreal, Canada

Dec 2005 “The Impact of the New Guidelines for Lung Transplantation”, CME Course on Advances

in Pulmonary and Critical Care Medicine. Classic Problems 21st Century Solutions. 7th

Annual Conference, Columbia University College of Physicians and Surgeons, New York,

NY

Jan 2006 “Approach to Diffuse Parenchymal Lung Disease”, Medical Grand Rounds, St Vincent’s


Feb 2006 “Lung Transplantation: State of the Art in 2006”, 2006 Annual Scientific Assembly,

American Thoracic Society and the New York State Thoracic Society, West Point, NY

Mar 2006 “Critical Care of Lung Transplant Recipient”, Critical Care Lecture Series, NewYork

Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New

York, NY

Mar 2006 “Pulmonary Complications Following Lung Transplantation”, Pulmonary Grand Rounds,

St Luke’s Roosevelt Medical Center, New York, NY

Apr 2006 “Overview of Lung Transplantation”, Pulmonary Grand Rounds, Beth Israel Medical

Center, New York, NY

May 2006 “Can I Take Care of My Patient After Lung Transplantation and How? A Guide To

Integrated Management of a Lung Transplant Recipient in the Community”, Meet the

Professor Seminar, American Thoracic Society 2006 International Conference, San Diego,

CA

June 2006 “Medical Advances in Lung Transplantation. Transplantation Lecture Series”, Medical

Grand Rounds, NewYork Presbyterian Hospital, Columbia University College of


Sep 2006 “Lung and Heart-Lung Transplantation. State of the Art in 2006.” ONKKD Transplantation

2006 Fifth Congress. Cesme, Izmir, Turkey

Oct 2006 “Update to the Candidate Selection of Patients with Cystic Fibrosis for Lung

Transplantation”, Panel Discussion on Selecting Lung Transplant Candidates: Guidelines


41

Update for the General Pulmonologist, American College of Chest Physicians, CHEST

2006, Salt Lake City, UT

Nov 2006 “Lung Transplantation. State-of-the-Art in 2006”, Medical Grand Rounds, Dept of

Medicine, St. Vincent’s Hospital, New York, NY

Nov 2006 “Updates on Advances in Lung Transplantation”, Pulmonary Medicine for the Primary

Care Practitioner: Classic Problems, 21st Century Solutions. 8th Annual CME Conference,


Jan 2007 “Diffuse Parenchymal Lung Diseases”, Medical Grand Rounds, St Vincent’s Medical

Center, Bridgeport, CT

Mar 2007 “Lung Transplantation for Advanced Lung Disease. For Whom, When and How?” CME

Conference, Columbia University College of Physicians and Surgeons, New York, NY

Apr 2007 “Novel Immune Therapies for Bronchiolitis Obliterans Syndrome” Sunrise Symposium 2

on State-of-the-Art Management Options for Bronchiolitis Obliterans, International

Society for Heart and Lung Transplantation, 27th Annual Meeting, San Francisco, CA

May 2007 “Pulmonary Complications of Lung Transplantation for Non-transplant Pulmonologists”,

Pulmonary Grand Rounds, Winthrop Medical Center, New York, NY

May 2007 “Lung Transplantation Should Be Embraced By All Pulmonologists: A Critical Review of

Benefits and Risks”, Meet-the-Professor Session MP509, American Thoracic Society 2007

International Conference, San Francisco, CA

June 2007 “Lung Transplantation. State-of-the-Art in 2007”, Cardiothoracic Grand Rounds, Ege

University School of Medicine, Izmir, Turkey

June 2007 “Keeping Your Lungs Healthy. Avoiding Air Pollution, Cigarettes and Obesity”,

Symposium on Promotion of Heart and Lung Health, NewYork-Presbyterian Hospital and

Intermed Medical Center, Istanbul, Turkey

Sep 2007 “Lung Transplantation. Current Indications and Outcomes”, 24th Annual Clinical Update

of Pulmonary Disease, Deborah Heart and Lung Center CME Course, Philadelphia, PA

Sep 2007 “Management of the Lung Failure Patient. From Screening to Lung Transplantation”,

Columbia University College of Physicians and Surgeons, Dept of Surgery CME talk,

Orange County, NY

Oct 2007 “Functional Outcomes Following Lung Transplantation”, Panel Discussion: Lung

Transplantation: What Constitutes a Successful Outcome? Chest 2007, Chicago, IL

Oct 2007 “Advances in Lung Transplantation. Patient Selection and Management”, Medical Grand

Rounds, New York Downtown Hospital, New York, NY

Nov 2007 “Living Lung Transplants: New Developments”, Extending Life Through Transplantation,

Columbia Presbyterian Health Sciences Advisory Council Conference, Morgan Stanley

Children’s Hospital, New York, NY


42

Dec 2007 “Diffuse Lung Disease. Diagnostic Approach”, Medical Grand Rounds, Dept of Medicine,

St. Vincent’s Hospital, New York, NY

Feb 2008 “Management of the Lung Failure Patient. From Screening to Lung Transplantation”,

Columbia University College of Physicians and Surgeons, Dept of Surgery CME talk, New

Brunswick, NJ

Mar 2008 “Management of the Lung Failure Patient. From Screening to Lung Transplantation”,

Columbia University College of Physicians and Surgeons, Dept of Surgery CME talk, New

York, NY

Apr 2008 “Can Bronchiolitis Obliterans Syndrome Be Blocked?”, Sunrise Symposium 4 on

Personalized Immunosuppression-Myth or Reality?, International Society of Heart and

Lung Transplantation 28th Annual Meeting and Scientific Sessions, Boston, MA

Apr 2008 “Variability in the Pathologic Interpretation of Transbronchial Lung Biopsy After Lung

Transplantation. Clinical Implications”, Concurrent Session on Challenges in Pathology of

Thoracic Transplants, International Society of Heart and Lung Transplantation 28th Annual

Meeting and Scientific Sessions, Boston, MA

Apr 2008 “Lung Failure From Screening, Endoscopic LVRS to Lung Transplantation:

Management Options”, Columbia University College of Physicians and Surgeons, Dept

of Surgery CME talk, Garden City, NY

June 2008 “Lung Transplantation for the Intensivist”, Critical Care Grand Rounds, NewYork-

Presbyterian Hospital, Columbia University College of Physicians and Surgeons, NY

Sep 2008 “The management of end-stage lung disease. The role of lung transplantation”, Columbia

University College of Physicians and Surgeons, Dept of Surgery CME talk, Stamford, CT

Nov 2008 “The management of advanced lung disease. Medical management and the role of lung

transplantation in 2008”, Columbia University College of Physicians and Surgeons, Dept

of Surgery CME talk, Hackensack, NJ

Dec 2008 “Lung transplantation. Sicker Patients, Improving Outcomes”, Heart Failure and Heart

Transplantation Program Grand Rounds, NewYork-Presbyterian Hospital, Columbia

University College of Physicians and Surgeons, NY

Jan 2009 “Debate: The use of thrombolytic therapy in submassive pulmonary embolism. Con”, New

State Thoracic Society Annual Scientific Assembly, West Point, NY

Apr 2009 “Interventions for advanced lung disease. Lung volume reduction surgery and lung

transplantation”, Medical Grand Rounds, Staten Island University Hospital, Staten Island,

NY

Apr 2009 “Lung Transplantation 2009”, Pulmonary Grand Rounds, Beth Israel Medical Center, New

York, NY

May 2009 “Treatment of advanced lung disease”, Medical Grand Rounds, St Vincent’s Medical

Center, Bridgeport, CT


43

May 2009 “Managing co-morbidities of lung transplantation”, Postgraduate course PG19; Lung

Transplantation: State of the Art, American Thoracic Society Annual International

Meeting, San Diego, CA

May 2009 “Approach to diffuse lung disease”, Housestaff Teaching Conference, St Vincent’s


Oct 2009 “New Horizons in Lung disease and Transplant Care”, James Lenox Society symposium,

Lotos Club, New York, NY

Nov 2009 “Should Older Patients Undergo Lung Transplantation”, Panel Discussion on

Controversies in Patient Selection for Lung Transplantation, CHEST 2009 Annual

Meeting, San Diego, CA

Jan 2010 “Lung Transplantation for Idiopathic Pulmonary Fibrosis”, Webinar sponsored by the IPF

Foundation, New York, NY

May 2010 “Lung Transplantation: 2010 Update”, Lung Health 2010, The International Year of the

Lung, Interdisciplinary Symposium sponsored by Columbia University, COPD Foundation

and 1199 SEIU, New York, NY

Oct 2010 “Introduction to the Lung Allocation System in the United States”, Clinical Controversy,

Lung Allocation System in the United States: Implications for the Patient with Advanced

Lung Disease, Chest 2010, Vancouver, BC, Canada

Oct 2010 “Medical Therapies for Advanced Lung Disease: Do’s and Dont’s”, Panel Discussion,

State-of-the-Art Management of End Stage Lung Disease, Chest 2010, Vancouver, BC,

Canada

Apr 2011 “Acute cellular rejection, the sensitized recipient and immunosuppression regimens post-lung

transplantation”, ISHLT Academy: Core Competencies in Lung Transplantation, International

Society for Heart and Lung Transplantation 31st Annual Meeting, 2011, San Diego, CA

Apr 2011 “Should we be transplanting patients from the intensive care unit?” Pre-meeting

Symposium 2. Optimizing Lung Allocation. Square Pegs in Round Holes, International

Society for Heart and Lung Transplantation 31st Annual Meeting, 2011, San Diego, CA

Apr 2011 “2011 State-of-the-Art In Lung Transplantation”, Medical Grand Rounds, Saint Vincent’s


Apr 2011 “Management of Interstitial Lung Disease”, Medical Grand Rounds, Saint Vincent’s


Apr 2011 “Advanced Management of End-Stage Lung Disease: The Role of Lung Transplantation”,

Management of the Lung Failure Patient, Columbia University College of Physicians and

Surgeons, Dept of Surgery CME Program, Garden City, NY

Jun 2011 “Lung Transplantation. State-of-the Art in 2011”, Columbia Annual Nurses’ Symposium,

Continuing Education Program, NewYork Presbyterian, The University Hospital of

Columbia and Cornell, New York, NY


44

Sep 2011 “Lung Transplantation Update”, Grand Rounds, Division of Infectious Disease, Dept of

Medicine, Columbia University College of Physicians and Surgeons, New York, NY

Mar 2012 “Lung Transplantation in Interstitial Lung Disease and Pulmonary Fibrosis”, Interstitial

Lung Disease: Recognition and Treatment, CME Program, Columbia University College

of Physicians and Surgeons and NewYork-Presbyterian Hospital, White Plains, NY

Jun 2012 “Lung Transplantation in Interstitial Lung Disease and Pulmonary Fibrosis”, Interstitial

Lung Disease: Recognition and Treatment, CME Program, Columbia University College

of Physicians and Surgeons and NewYork-Presbyterian Hospital, Hackensack, NJ

Nov 2013 “International Collaboration in Lung Transplantation”, Seventh International Health

Tourism Congress. Istanbul, Turkey

Nov 2013 “Lung Transplantation. 2013 Update”, Medica Health Clinic, Istanbul, Turkey

Oct 2014 Symposium and Workshop in Lung transplantation, Overview and Case Presentations,

Speaker and Moderator, Turkish Thoracic Society and Turkish Society of Chest Surgery,

Istanbul, Turkey

Mar 2016 Optimizing Lung Donor Care. Organizer and Moderator, CME symposium hosted by

LiveOnNY, Columbia University Medical Center and NewYork-Presbyterian Lung

Transplant Program, Brooklyn, NY

June 2016 Optimizing Lung Donor Care. Organizer, Moderator and Speaker: State-of-the-Art in Lung

Transplantation, CME symposium hosted by LiveOnNY, Columbia University Medical

Center and NewYork-Presbyterian Lung Transplant Program, West Chester, NY

Sep 2016 Optimizing Lung Donor Care. Organizer, Moderator and Speaker: State-of-the-Art in Lung

Transplantation, CME symposium hosted by LiveOnNY, Columbia University Medical

Center and NewYork-Presbyterian Lung Transplant Program, Westbury, NY

Jan 2017 Overview of Lung Transplantation. Medical Grand Rounds, Saint Barnabas Health Sytem,

Bronx, NY

Mar 2017 Lung Transplantation for End-Stage Lung Disease. 2017 Update. Innovative Therapeutics

for Advanced Lung Disease. CME course sponsored by Department of Surgery, NewYork-

Presbyterian Hospital/Columbia University Medical Center, New York, NY

Mar 2017 The Past, Present and Future of Lung Transplantation. Medical Grand Rounds, Columbia

University Medical Center, Department of Medicine, New York, NY

Apr 2017 Lung Allocation Score Controversies. Improving Equity in Organ Allocation. Symposium

entitled Lung Allocation Scores (LAS): Making the Complex Simple, or Just the Simple

Complex. International Society for Heart and Lung Transplantation 37st Annual Meeting,

2017, San Diego, CA

May 2018 Lung Transplantation for Cystic Fibrosis. It Takes an Army! Educational Talk for Stony

Brook University and Northwell Hospital Cystic Fibrosis Programs, Huntington, NY


45

June 2018 Lung Transplantation. State of the Art in 2018. Current Status and Future Advances in

Organ Transplantation. The 15th Hallym-Columbia-Weill Cornell-NYP International

Symposium. Seoul, South Korea

Media Appearances:

Doctor Radio, SiriusXM Radio, two live interviews and Q&A regarding lung transplantation

Aksam. Turkish newspaper. Article on Promotion of Lung Health. June 30, 2005.

Gunaydin. Turkish newspaper. Article on Health Hazards of Smoking and Lung Transplantation. June 30,

2005.

Contribution to an article on Lung Allocation System in the New York Times. Lung Patients See a New

Era of Transplants by Denise Grady. Vol CLVI. No 53,712. September 24, 2006

Zaman Amerika. Turkish daily newspaper. Effects of Smoking on Lung Health. April 3, 2010.

News story about 2 girls with cystic fibrosis who underwent lung transplantation at our center, ATV,

Turkish TV channel. October 2013.

Medica Magazine Interview. Advanced Lung Disease and Lung Transplantation. March 2014 Report. No

8; pp 4-8.

WABC Channel 7 News. Medical Marvels: Double Lung Transplant. A story about a patient who

underwent 2 lung transplant operations 12 years apart on the same date. July 30, 2014

CBSNewYork. Boomer Esiason Foundation’s Bike to Breathe Encourages Cystic Fibrosis Patients to Stay

Active. September 24, 2015

Crossing the Bridge of Eastern and Western Cultures: Lung Transplantation in Turkey. International

Society of Heart and Lung Transplantation Links, Vol 7, Issue 1, May 2015.

Breath of Life Elusive for Queens Woman--And Many New Yorkers. Interview with Fred Mogul. WNYC

News. Nov 23, 2015.

columbia university college of physicians and …

Documents